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Abtract
Recurrence in tuberculosis is a serious health problem. To understand recurrence it is necessary
to understand the risk factors associated and how that information can impact future strategies.
To achieve this purpose, data from the SVIG-TB database was analyzed. Only patients diag-
nosed with their first episode of TB between 2002 and 2009, in Portugal, were included. The
BCG vaccination was one of the most interesting variables to include in the analysis due to the
long-lasting discussion about the protective effect of the vaccine. However, using this variable
lead to a problem with the amount of missing data in the dataset.
Therefore, to avoid discarding the variable Vaccine and lose the information regarding patients
with missing information several techniques of multiple imputation were used: Predictive Mean
Matching, two different models of Random Forest and a model of Expectation-Maximization
with Bootstrapping. To compare the results obtained, models were fitted to the complete
dataset, the complete dataset without the Vaccine and a dataset imputed by mean imputation.
The model fitted to the complete dataset without the Vaccine discarded the variable HIV
and included the variable regarding Residence Community presenting the most distinct results
compared with the other models. Mean imputation, imputation via maximum likelihood and
Random Forest missForest selected the same variables (Vaccine, Clinical Form, Situation,
Alcohol, Prison, HIV, Diabetes and age). Random Forest missForest and imputation via
maximum likelihood presented the most consistent results. These results suggests that the
majority of the recurrence cases may be due to relapse since extrapulmonary TB, younger age
and HIV are associated with relapse.
To conclude, inclusion of information about treatment noncompletion, drug resistance and
genotyping data (to distinguish between relapse and reinfection) is essencial. Imputation
should be implemented in case of missing information since it carries less assumptions that
performing a complete case analysis.
Keywords: Tuberculosis; Recurrence; Multiple Imputation; Survival Analysis
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Resumo
A recorrência em tuberculose, seja devido a recaída ou a reinfecção, é um grave problema de
saúde pública. A proporção de pacientes multi resistentes ou extensivamente resistentes aos
antibióticos é maior entre os casos recorrentes. Algumas medidas precisam de ser implemen-
tadas de maneira a reduzir a frequência de casos recorrentes. Para compreender a recorrência
é necessário compreender os factores de risco associados, o seu papel e como essa informação
pode afectar estratégias futuras. O objectivo desta tese é analisar casos recorrentes de tuber-
culose de maneira a identificar covariáveis que influenciam o tempo desde o fim do primeiro
episódio até ao início do segundo episódio.
Para atingir este propósito, dados do SVIG-TB foram analisados. Apenas pacientes diagnos-
ticados com o seu primeiro episódio entre 2002 e 2009, em Portugal, foram incluídos. A
realização da vacina BCG era uma das variáveis mais interessantes para incluir devido a per-
durável discussão sobre o efeito protector da vacina. No entanto, usar esta variável leva a um
problema de dados omissos na base de dados. Os dados omissos variam entre um baixo valor
de 0.03% para a Forma Clínica até um elevado valor de 59% para a Vacina. Uma possível
explicação para a diferente quantidade de dados omissos poderá ser que cada centro de saúde
pergunta questões ao paciente, inserindo essa informação no SVIG-TB. Provavelmente, alguns
centros de saúde dão mais importância a algumas variáveis enquanto outros centros ignoram
essas variáveis.
Portanto, para evitar descartar a variável Vacina e perder a informação referente aos pacientes
com dados omissos várias técnicas de imputação múltipla foram usadas. Um modelo foi
ajustado aos dados completos de forma a comparar os resultados com os resultados obtidos por
modelos ajustados a base de dados com os valores imputados. Um modelo foi também ajustado
aos dados completos sem a variável Vacina de modo a compreender as implicações de descartar
uma variável com uma grande proporção de dados omissos. Uma base de dados "completa"foi
obtida através de imputação por substituição da média de modo a comparar os resultados
de imputação simples com imputação múltipla. Vários métodos de imputação múltipla foram
usados: Predictive Mean Matching, dois modelos diferentes de Random Forest e um modelo de
Expectation-Maximization with Bootstrapping. Predictive Mean Matching apresenta, no geral,
resultados consistentes na literatura. Investigação recente apresenta vantagens em imputar
dados com Random Forest e Expectation-Maximization with Bootstrapping imputa dados via
a máxima verosimilhança.
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Esta análise alerta para o perigo de descartar uma variável para efectuar uma análise de da-
dos completos. De facto, este modelo rejeitou a variável HIV e incluíu a variável relacionada
com a Residência Communitária apresentando os resultados mais distintos comparado com
os restantes modelos. A variável Álcool e Diabetes não foi significativa no modelo ajustado
aos dados completos, sendo a última excluída devido a um problema de separação completa.
Imputação por substituição da média, imputação via máxima verosimilhança e Random For-
est missForest seleccionaram as mesmas variáveis (Vacina, Forma Clínica, Situação, Álcool,
Prisão, HIV, Diabetes e idade). O modelo ajustado aos dados imputado por Predictive Mean
Matching apresentou resultados semelhantes para as estimativas comparando com os restantes
modelos; no entanto, não incluíu Prisão e Vacina. As duas técnicas implementadas de Random
Forest tiveram resultados semelhantes mas o package mice é extremamente lento. Random
Forest missForest e imputação via máxima verosimilhança apresentaram os resultados mais
consistentes.
Como esperado, as estimativas dos coefficientes e os erros padrão do modelo ajustado aos
dados completos são maiores que as estimativas dos modelos ajustados aos dados imputados.
Os valores de R2 and C são mais elevados que nos modelos ajustados aos dados imputados
no entanto estes valores não podem ser correctamente comparados uma vez que os modelos
são baseados em conjuntos de dados diferentes. As estimativas dos coefficientes e erros
padrão, entre imputação simples e múltipla imputação, são muito semelhantes, excepto para
a variável Prisão que possui um ligeiro aumento da estimativa do coefficiente. De realçar que
imputação simples não introduz variabilidade no modelo, ignorando que os valores não são
todos verdadeiros.
Ambos os modelos ajustados aos dados imputados por Expectation-Maximization with Boot-
strapping e por Random Forest missForest produzem resultados adequados. No entanto, não
é possível seleccionar o "melhor"método de imputação. Cada base de dados deve ser tratada
independentemente. Uma série de escolhas (como o número de imputações, o número de
iteracções, o método ou métodos para imputar os dados, como incorporar interacções e não-
linearidades, etc) devem ser consideradas e ser tratadas com cuidado uma vez que escolhas
erradas levam a estimativas incorrectas.
Muitos estudos debatem sobre a eficácia da vaccina BCG embora a maior parte apenas ignore
este problema e não adiciona informação sobre a vaccinação no modelo. A vaccina foi incluída
neste estudo e verificou-se significativa em alguns modelos. O efeito estimado para a variável
BCG varia de 56% (modelo ajustado aos dados imputados por Expectation-Maximization with
Bootstrapping) até 80% (análise de casos completos). Este resultado indica que pessoas não
vacinadas tem um risco maior de sofrer um novo episódio de tuberculose comparado com
pessoas vacinadas. O risco de um episódio recorrente para um indivíduo com uma forma
extrapulmonar é entre 1.86 vezes (modelo ajustado aos dados imputados por Expectation-
Maximization with Bootstrapping) até 2.59 vezes (modelo ajustado aos dados completos)
o de um indivíduo com uma forma pulmonar de tuberculose. O risco de recorrência para
indivíduos que desistiram do tratamento é entre 3 vezes (modelo ajustado aos dados imputados
por Expectation-Maximization with Bootstrapping) até 9 vezes (valor semelhante para os
restantes modelos) o de indivíduos que completaram o tratamento. Um indivíduo alcoólico
tem um aumento entre 70% a 80% no risco de recorrência que um indivíduo sem problemas
alcoólicos. As estimativas do coefficiente para a variável Prisão são mais diversas. O risco
de recorrência para alguém preso é entre 3 vezes (modelo ajustado aos dados imputados por
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Expectation-Maximization with Bootstrapping) até 10 vezes (análise de dados completos) o
de alguém que não está na prisão. O risco de um episódio recorrente para um indivíduo com
HIV é entre 1.93 vezes (modelo ajustado aos dados imputados por Expectation-Maximization
with Bootstrapping) até 3.29 vezes (modelo ajustado aos dados completos) o de um indivíduo
sem HIV. Os resultados obtidos para as estimativas do coefficiente da variável Diabetes foram
surpreendentes. A análise mostrou que indivíduos com Diabetes tem uma diminuição de
80% no risco comparado com indivíduos sem Diabetes. Em Portugal, a taxa de indivíduos
não diagnosticados é de 43%, o que pode levar a uma subestimação do verdadeiro efeito da
variável Diabetes. Um aumento de um ano de idade leva a uma diminuição de 1% a 2% no
risco de recorrência.
No entanto, é provável que algumas destas variáveis estejam correlacionadas com variáveis que
não foram medidas, em particular, com a aderência ao tratamento e o estado da doença ao
iniciar o tratamento. Estes resultados sugerem que a maioria dos casos de recorrência podem
ser devido a uma recaída uma vez que tuberculose extrapulmonar, idade jovem e HIV são
factores associados a recaída.
Para concluir, estudos adicionais são necessários para confirmar estes resultados. Incluir infor-
mação acerca da aderência ao tratamento, da resistência aos antibióticos e dados de genoti-
pagem (para distinguir entre recaída e reinfecção) é essencial. Em casos de dados omissos
deve ser realizada uma imputação de dados uma vez que possui menos suposições que realizar
uma análise de casos completos. Uma análise exaustiva deve ser realizada de modo a avaliar
o método mais apropriado para a imputação.
Keywords: Tuberculose; Recorrência; Múltipla Imputação; Análise de Sobrevivência
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Chapter1
Introduction
1.1 Some facts about tuberculosis
Human tuberculosis (TB) is an airborne infectious disease that may affect the lungs
(pulmonary TB) or other parts of the body (extrapulmonary TB). The most commom form
of TB is pulmonary but both forms can also co-exist. Tuberculosis can have a wide range of
symptoms such as cough, chest pain, shortness of breath, fatigue, fever or weight loss. It is
transmitted when people infected with pulmonary TB cough or sneeze.
The causative agents of TB are grouped in the Mycobacterium tuberculosis complex
(MTBC):Mycobacterium tuberculosis (Mtb),Mycobacterium bovis,Mycobacterium africanum,
Mycobacterium canneti and Mycobacterium microti (1). Mtb is responsible for most cases
of TB and although it can affect animals, humans are the main hosts. Mycobacterium bovis
was also a public health concern in the early twentieth century due to infection from the con-
sumption of unpasteurized or unboiled milk, but with the introduction of pasteurized milk the
number of cases infected with this species has decreased significantly (1; 2). Mycobacterium
africanum represents more than half of the cases in Africa, being more common in HIV in-
fected patients; however, it is not widespread (3; 4). Mycobacterium canetti is rare and seems
to be limited to Africa (5). Mycobacterium microti natural hosts are small rodents and it is
uncommon in humans, the few cases found were immunodeficient people. However, several
studies claim that the prevalence may be underestimated (6; 7). Regarding other mycobacteria,
Mycobacterium leprae and Mycobacterium lepromatosis are the pathogens that cause leprosy,
while Mycobacterium avium and Mycobacterium kansasii are Nontuberculous mycobacteria
(NTM) which cause pulmonary diseases that resemble TB. Although, Mycobacterium avium
and Mycobacterium kansasii are not contagious, their prevalence is increasing (8).
Most tuberculosis infections are asymptomatic and latent. However, one in ten latent infections
eventually progresses to active disease which, if left untreated, kills approximately 66% of
infected people. An untreated person with active disease can infect 10 to 15 people per year,
but if treated and diagnosed promptly this rate lowers considerably (9). If left untreated,
tuberculosis can last for years and become a chronic disease. The progression towards an
active disease seems to be related to the immune system. A depressed immune response at
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the time of infection increases the risk for active disease, and, in the same way, for someone
already infected the risk for reactivation increases when his immunity is low (1; 10). A detailed
explanation of the infection process can be seen in figure 1.1.
Figure 1.1: Natural history of tuberculosis in newly infected contacts (10)
There are several known risk factors for TB infection. Nowadays, the most important risk
factor is HIV - instead of the usual 10% progress rate, 30% of those co-infected with HIV
develop active disease. Other important risk factors are overcrowding, malnutrition, addiction
to drugs or alcohol, smoking, high-risk ethnics, being children in contact with high-risk patients
or health-care workers (1; 11; 12). In fact, individuals with prolonged or close contact with
people with TB are at high risk of infection. (9)
At the moment, TB is typically diagnosed using chest X-ray and sputum cultures. Molecular
tests are also used to diagnose TB, particularly, for multi drug resistant TB (MDR). The only
vaccine available today is bacillus Calmette-Guerin (BCG), which although effective against
disease in children, it confers inconsistent protection against pulmonary TB in adults. Nev-
ertheless, new drugs and vaccines are being tested in clinical trials (12). New cases of TB
are typically treated following a 6 month regimen of four first line drugs: isoniazid, rifampicin,
ethambutol and pyrazinamide. In case of MDR TB (resistance to at least isoniazid and ri-
fampicin) the treatment can last up to 20 months and requires the use of second line drugs
such as kanamycin, capreomycin and amikacin (12).
1.2 Tuberculosis history
More than a decade ago, researchers believed that Mycobacterium bovis was the ances-
tor of Mtb. This hypothesis was based on the fact that Mtb is a human pathogen, whereas
Mycobacterium bovis can infect both animals and humans. However, this theory has been
disproved after the complete sequencing of their genomes. The results indicate that Mycobac-
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terium bovis has a smaller genome due to numerous deletions 1 when compared with Mtb,
thus it is likely that Mycobacterium bovis evolved from Mtb and not the other way around.
The transition from humans to animals may be linked to animal domestication that occurred
13 000 years ago (13; 14).
”Phthisis”, a term used in pulmonary TB that means consumption, appeared first in Greek
literature. Hippocrates identified phthisis around 460 BCE, giving an accurate description of
the characteristics of the disease: fever, colorless urine, cough, and loss of thirst and appetite.
He also noted that it was almost always fatal (15; 16).
In the 18th-19th centuries, TB imposed a high burden to society because of the life conditions
in cities due to the Industrial Revolution [17]. In Bristol, between 1790 and 1796, 683 out of
1571 deaths were due to TB. In Shropshire, between 1750 and 1759, the rate of death was
one in six, ten years later, the rate of death was one in three.
In 1720, the English physician Benjamin Marten proposed in his publication A New Theory
of Consumption that TB, known at the time as consumption, could be caused by ”creatures”
that could cause lesions and symptoms of the disease. Marten’s writings displayed a good
understanding of the disease for the time. However, his work was completely discarded and it
took more than one century before Robert Koch demonstrate it to be true (16).
A description of tuberculosis meningitis was given by Robert Whytt, in 1768. And Percivall
Pott correctly described the vertebral lesions of tuberculosis vertebral, also known as Pott’s
disease, in 1779. Around the same time, William Stark suggested that different forms of TB
were in fact different manifestations of the disease. Unfortunately, Stark’s observations were
ignored after his death while studying scurvy.
In his 1819 book, D’Auscultation Mediate, Laennec, who is best remembered for his invention
of the stethoscope, clearly elucidated the pathogenesis of TB and described most of the phys-
ical signs of pulmonary disease. Indeed, modern understanding of TB began with Laennec’s
treatise.
In 1854, Hermann Brehmer presented his doctoral thesis Tuberculosis is a Curable Disease,
after having returned cured of TB from a trip to the Himalayan Mountains. At the same time,
he built an institution in Gorbersdorf, Germany, where among trees and with good nutrition,
patients were exposed to a healthier climate. This led to the introduction of sanatorium which
was a significant mark in the history of TB (16).
In 1869, the French military doctor Jean Antoine Villemin demonstrated that the disease was
contagious, after conducting an experiment in which tuberculous from human cadavers were
injected into laboratory rabbits, who then became infected (16).
When Robert Koch incubated the bacteria, a breakthrough in tuberculosis happened. He
named tuberculosis bacillus, after some inoculated laboratory rabbits died with symptoms of
tuberculosis. This was the prove that the bacilus was the cause of tuberculosis. He made
his result public at the Physiological Society of Berlin on 24 March 1882, in a famous lecture
entitled Über Tuberculose, where he demonstrated that Mycobacterium was the single cause
of tuberculosis in all of its forms. Since 1882, 24 March has been known as World Tuberculosis
Day.
1Deletion is the loss of genetic material.
3
Chapter 1. Introduction
Koch’s contributions to bacteriology were remarkable and he was awarded the Noble Prize in
Medicine or Physiology in 1905 for his elucidation of the etiology of tuberculosis.
Another mark in the history of TB was the discovery of the X-ray, by Wilhelm Roentgen in
1895. This invention led to better diagnosis and, consequently, to a decline in TB incidence
and mortality (15).
A more direct approach to tackle the public health challenges of TB was taken by Albert
Calmette and his associate Camille Guérin. In the Pasteur Institute of Lille, where Calmette
was the director, the researchers tried to use Mycobacterium bovis as a vaccine. As a result
of their work, BCG was tested for the first time in 1921. The recipient was an infant born to a
mother dying of pulmonary tuberculosis and placed in the care of a tuberculous grandmother.
The child survived and did not develop tuberculosis.
In 1948, a campaign to control tuberculosis with the sponsorship of the UNICEF and the Danish
Red Cross was undertaken. It started in Poland and spread to other European countries and
ultimately to Ecuador. During the campaign, nearly 14 million people were vaccinated with
BCG. This was the first disease control program undertaken by an agency of the World Health
Organization (15).
After the introduction of chemotherapy the history of tuberculosis changed. In 1944, in
the USA, Albert Schatz, Elizabeth Bugie, and Selman Waksman isolated streptomycin, the
first antibiotic effective against Mtb. Since the amount of streptomycin available from the
USA was limited, it was ethically acceptable for the control group to be treated without the
drug and therefore the first randomized control trial was conducted, in 1946, by the United
Kingdom Medical Research Council (17; 18). Isoniazid, the first oral mycobactericidal drug,
was developed in 1952, followed by rifampicin in 1957 (15).
Despite many efforts to fight TB, hopes of erradicating the disease were dashed after the
appearance of drug-resistant strains in the 1980s. The resurgence of tuberculosis resulted in
the declaration of a global health emergency by the World Health Organization in 1993. Along
with HIV and malaria, TB has been declared a global enemy (12; 19).
1.3 Tuberculosis worldwide
TB causes ill-health among millions of people each year and it ranks as the second leading
cause of death from an infectious disease worldwide, after HIV. A global overview of this
epidemic disease can be seen in figure 1.2.
In 2011, 8.7 million people were diagnosed with TB as new cases, 13% being co-infected with
HIV. In that year, 1.4 million people died from TB, among them 430 000 were HIV-positive.
Almost 80% of TB cases co-infected with HIV come from Africa. TB is also the third cause
of death among women between 15-44 years in low-income countries and the fifth worldwide
among women between 20-59 years. It is estimated that 2 billion people have latent TB and
half million children are infected worldwide (12).
Figure 1.3 represents the proportion of MDR cases. It is estimated that 3.7% of new cases and
20% of previously treated cases are MDR. Country-wise, India, China, the Russian Federation
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Figure 1.2: Estimated TB incidence rates, 2011 (12)
and South Africa are clearly hotspots for MDR, representing almost 60% of the world’s cases
of MDR. This figure is a clear representation of the importance of identifying recurrent cases.
Figure 1.3: Weighted mean of MDR-TB in new and retreatment TB cases between 1994 and
2007. b data from 105 countries, c data from 94 countries (20)
In places where the transmission of TB is stable or increasing, the incidence of TB cases is
higher among young adults and most cases are due to recent infection or reinfection. On the
other hand, if transmission decreases, the incidence of TB is higher in old adults and the cases
are attributable to reactivation of a latent infection. In countries with low incidence rates, such
as Western Europe and North America, indigenous patients tend to be older whereas younger
patients are mostly immigrants from high-incidence countries (21).
The STOP TB Strategy and the Global Plan to Stop TB, currently in execution, were launched
in 2006 by the World Health Organization (WHO). These plans aim to address major TB
problems, namely, weak health systems, the epidemics of HIV-associated TB and the emergence
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of MDR. WHO set a few targets in the control of TB. One of the targets is, to reduce the
prevalence of TB and the deaths due to TB by 50% compared with the baseline of 1990 by
2015. The aim for 2050 is to eliminate TB as a public health problem, defined as a worldwide
incidence of TB of less than 1 case per million per year. However, the target for 2015 is
unlikely to be met worldwide due to the epidemics of HIV-associated TB in Africa and the
emergence of MDR tuberculosis in Eastern Europe.
1.4 Tuberculosis in Portugal
According to the national health report, in 2011, Portugal had 2388 diagnosed cases of
TB, including new and recurrent cases. Of those, 2016 were from Portuguese patients and 372
(16.6%) were from foreigners. At the moment, Portugal is a medium-incidence country, with
an annual decrease of 6.4% since 2002. Most of TB cases are concentrated in the metropolitan
areas, such as Lisboa, Porto, Setúbal, Braga and Beja, as depicted in figure 1.4 (22).
Figure 1.4: Geographic distribution of new cases of TB, in 2011 (22)
In 95% of the total number of cases, the diagnostic was made when symptomatic patients
sought medical care and only 5% were detected through screening. Most of the infected
patients had pulmonary disease (73%) and, among these, 8% also had lesions in other parts
of the body. Among foreigners, the proportion of cases is stable since 2004, representing 16%
of the total of cases. This is the lowest proportion of cases among foreigners, in the European
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Union. However, a foreigner has still an higher risk (four times higher) than a local to acquire
TB. Through the National report (22), it is possible to notice the decreased risk of tuberculosis
in all age groups, more pronounced between 24 and 44 years. In 2010, 89% of TB cases were
tested for HIV and 12% of them had a positive result. This rate is one of the highest in all
EU. In fact, TB is the leading cause of death among people with HIV, being responsible for
about 40% of deaths. In 2011, MDR represented approximately 1.7% of the cases of TB (1.3%
among new cases and 8.2% in recurrent cases). This proportion is somewhat smaller than the
average one across EU (22).
Following EU Health policies, the main goals for the Portuguese Directorate General for Health
(DGS) are the detection of at least 70% of the cases and the cure of 85% of TB cases per
year. At the moment, Portugal is one of the seven EU countries to reach the aimed detection
rate with 87% (corresponding to the blue line in figure 1.5). Regarding the therapeutically
success rate, Portugal is one of the three EU countries that consistently surpassed the 85%
threshold despite a recent drop to 77% (green line in figure 1.5) (22).
Figure 1.5: Rate of detection and therapeutically success (22)
1.5 Objectives of the thesis
The main goal of this project is to analyze recurrent cases of TB, in order to identify the main
risk factors for time to reccurence. Understanding the risk factors can help to minimize the
frequency of recurrence. Given the controversy surronding it, a secondary aim is to analyze
the protective effect of the BCG. However, there is a large number of patients for whom there
is no information about their BCG vaccination. Therefore, in order to consider this variable,
multiple imputation methods are used.
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SVIG-TB Database
2.1 Database description
The TB data that were analyzed came from SVIG-TB, an informatic application from the
”Programa Nacional de Luta Contra a Tuberculose”, from the Portuguese National Health
System.
Cases of TB disease, confirmed or probable, and cases of TB infection 1, detected in centros de
saúde, hospitals, prisons or centers for addictions treatment (CATs) are mandatory notified to
SVIG-TB (i.e. TB episode). In most cases the doctor fills in a form, by hand, with some of the
most relevant clinical and socio-demographic information about the patient. Afterwards, these
data are typed in and sent to SVIG-TB. This step, although important in the data collection,
is also one of the main source of errors and represents a limitation in the quality of the data.
WHO estimates that around 10% of the cases in Portugal are not detected and therefore not
notified to the SVIG-TB (12).
2.2 Criteria for inclusion and exclusion
The statistical analysis was conducted using data from patients diagnosed between 1st of
January 2002 and 31st December 2009. Although data from previous years are available they
do not constitute a good sample and were discarded from the analysis. For the same reason,
an upper limit was defined at the end of 2009. Data between 2002 and 2009 also have some
missing patients, however these are not significant and therefore these years are a appropriate
representation of the reality. Indeed, due to a slow update of the SVIG-TB database, the years
after 2009 are incomplete, and, therefore, were discarded. The data was also selected so that
only laboratory confirmed cases of TB 2 were used.
For the analysis of recurrent TB cases, patients without identification were removed from the
1TB disease refers to active TB while TB infection refers to latent infection, as explained in section 1.1.
2Disease caused by a bacteria from the MTBC.
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analysis. Without the identification number it was impossible to link episodes to a patient.
Recurrence is an episode occurring since the day the first treatment ended. Patients that died
during the first episode were also discarded as they died before ending the treatment. Some
outcomes, namely chronic TB and failure, were excluded since the number of patients with
these outcome were very low. Individuals whose follow-up time is smaller than 12 months were
also excluded from the analysis as they were considered not to have enough time for suffering
a recurrent case of TB.
2.2.1 Limitations of the database
As seen in section 2.2, the choice on the time period was limited on the starting and ending
dates of the collected data by SVIG-TB. Another serious limitation is the amount of missing
data. In fact, important information such as being vaccinated with BCG has more than 50%
of the data missing, and other relevant data, like radiology results, job of the patient, among
others, have between 5% and 10% missing data.
A recurrent episode may be due to endogenous reactivation, also named as relaspe or ex-
ogenous reinfection. To differentiate between relapse and reinfection genotyping methods are
needed. Relapse is defined when the two episodes of TB have identical or similar genotypes
while episodes with different genotypes are defined as reinfection (12; 23) Ideally, it would be
interesting to study the different risk factors for each case. However, molecular data on each
TB episode is not available in the SVIG-TB dataset. Other important clinical data that was
mostly absent from the used dataset was information on antibiotic resistance of the bacteria
and on the socio-economic status of the patient, both of which can have an impact on TB
infection. There is also a limitation with self-reported variables namely, use of drugs, alco-
hol, smoke etc. The patient could be not willing to share his addiction due to psychological
factors. This could be influenced by the fear of his physician reaction or the inability to see
his substance abuse as a problem. Whereas variables like date of symptoms consists of the
memory of the patient to record the first day he had symptoms.
2.3 Variable description
The variables considered in this study were previously reported as risk factors for TB in
the national and/or international literature. Some risk factors were not included since they
were absent from the SVIG-TB database. The variables considered can be divided in two
main categories: clinical variables (vaccine, clinical form of TB, time of diagnosis, radiology,
previous TB treatment, outcome, treatment duration, HIV, diabetes mellitus and number of
comorbidities) and socio-demographic variables (gender, age, country of origin, number of years
in Portugal, smoking habits, alcoholism, unemployment, drug abuse, prison, job, community
residence, homeless and transfered). Table 2.3.2 has a brief introduction of the variables
considered.
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2.3.1 Clinical variables
Vaccine is a binary variable representing whether the patient was vaccinated with BCG
or not. The vaccine protects against severe forms of TB in children (TB meningitis and
miliary TB), although it is not recommended for use in infants known to be infected with HIV
(12). Its efficacy in preventing pulmonary TB in adults, in the other hand, is highly variable
(12; 24). Another problem is in detecting BCG vaccination. Indeed, most studies refer only to
the presence or absence of a BCG scar, despite that although the presence of a scar confirms
vaccination, its absence does not confirm lack of it. In fact, some BCG-vaccinated children do
not develop a detectable scar (25).
Clinical form is a binary variable indicating if the patient has a pulmonary form of TB or an
extrapulmonary form. It is important to distinguish TB clinical forms since they can have very
different characteristics, namely, regarding the efficacy of BCG and the infectiousness of the
disease (12; 24).
Time to diagnosis is a continuous variable representing the time (in weeks) since the onset
of symptoms until the diagnosis. A late diagnosis may worsen the disease and increase the
risk of death. It can also enhance tuberculosis transmission in the community, since usually
the transmission occurs between the onset of symptoms and initiation of treatment (19; 26).
The recommended time until TB treatment (i.e. time to diagnosis and starting treatment) is
3 to 4 weeks, but in practice this is rarely the case (27; 28). Note that the onset of symptoms
was determined by retrospective self-diagnose which is likely not to be very accurate.
Radiology is a categorical variable, with the values: "Normal", "With cavitated lesions" and
"Without cavitated lesions". The term "Normal" indicates that the patient does not have any
lesion; "With cavitated lesions" indicates that the patient have cavitated lesions; "Without
cavitated lesions" indicates that the patient does not have cavitated lesions but have other
type of lesions. Detecting cavitated lungs is important, since these lesions were frequently
found to be significantly associated with recurrence risk (29; 30).
Previous TB treatment is a binary variable indicating if the TB case is the first infection of
the patient or a recurrent episode.
Patient outcome is a categorical variable corresponding to the final state of the disease
episode, which can be "death", "default" or "therapeutical success". The term "death" indi-
cates the occurrence of death of the patient by any cause during treatment; "default" corre-
sponds to the interruption of the treament by the patient for two or more consecutive months;
"therapeutical success" is defined by WHO as a TB case with positive culture having the
final outcome of ”cured” (Patient with positive culture at the beginning of treatment and
negative result at the end of treatment) or ”completed treatment” (Patient who completed
the treatment but does not have a negative culture at the end of treatment) (12), however,
in the SVIG-TB dataset obtaining an initial positive culture of TB-agent was not necessary
to consider ”therapeutical success”. Interestingly, previous studies showed that patients who
defaulted treatment were associated with an higher risk of having a recurrent episode of TB
(29; 30).
Duration of treatment is a continuous variable representing the time (in months) since the
beginning of treatment and until the outcome occurred ("death", "default" or "therapeutical
11
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success").
HIV is a binary variable indicating whether the patient has HIV or not. Having HIV is one of
the most important risk factor for progression of Mtb infection to active disease, and several
studies showed that HIV infection increases the risk of TB recurrence (29; 30).
Diabetes is a binary variable indicating whether the patient has diabetes mellitus or not.
Several studies indicated that patients with diabetes have an increased risk of failing the
treatment or of dying during TB treatment, and of relapse (31; 32).
Number of comorbidities is a discrete variable representing the number of diseases, other
than TB, that the patient suffers from, such as liver disease, sarcoidosis, silicosis, collagen
disease, chronic obstructive pulmonary disease, neoplasm or lymphomas.
2.3.2 Socio-demographic variables
Gender is a binary variable representing the gender of the patient. The relation male-female
in TB patients for Portugal is 2 to 1, which is similar to the rest of the EU, with an increasing
trend in males.
Age is a continuous variable representing the age of the patient (in years) at the time of
diagnosis. Several studies suggest that older adults may have an higher risk of death or
recurrent episodes (30; 33). However, linking old age with TB-related death can be difficult
since natural death also increases with age.
Country of origin is a categorical variable with the following values: "Born in Portugal",
"Born in a high risk country", "Born in a low risk country". According to WHO (34), when
the proportion of foreign-born cases exceeds 70% of the total reported cases, no greater than
2% decrease in annual TB incidence can be expected. This is not the case of Portugal, which
has one of the smallest rates of foreign-born cases, corresponding to a very small proportion
of the total cases. Anyhow, some studies showed an association between the country of origin
and TB recurrence. In fact, immigration from a high-burden country for TB has been shown
to be a major risk-factor in developed countries (30; 35).
Number of years in Portugal is a continuous variable representing the number of years for
which the patient has been living in Portugal.
Smoking habits is a binary variable representing whether the patient smokes or not. The
database had a free field where the physician could write the number of cigarettes smoked per
day or if the patient had stop smoking however, this information was very scarce. Hence, to
assess if the patient had smoking habits or not, a field smoker/non-smoker was used. Being
a smoker can be a particularly important factor in TB recurrence, since nicotine has been
associated to a higher chance to progress from latent infection to active infection (36).
Alcoholism is a binary variable indicating if the patient has an alcohol dependence or not.
Alcohol dependency is based on CAGE score. It is considered dependency if the patient has
a need to consume alcohol in the morning or if two of the following three criteria are met:
feel the need to quit alcohol; feel angry by receiving criticisms regarding alcohol; feel guilty to
drink. There seems to be a substantial risk increase of TB infection among people who drink
more than 40 g of alcohol per day, and/or have an alcohol use disorder (37).
12
2.3. Variable description
Unemployment is a binary variable indicating whether the patient has been unemployed for
more than 24 months. Unemployment is often associated with recurrence of TB, thus, this
variable was included in the study (30).
Drug abuse is a binary variable indicating whether the patient is a drug addict or not. Depen-
dency of drugs excludes the occasional use of drugs. Drug users remain a group at high risk
of TB infection and drug using has been occasionally reported as associated with recurrence
(29; 38).
Prison is a binary variable representing if the patient works in a prison or is an inmate.
Occurrence of active TB in prisons is usually reported to be much higher than the average level
reported for the corresponding general population. Overcrowding, late diagnosis, inadequate
treatment of infectious cases, precarious hygiene conditions, low quality of food and stress, are
all factors that favour transmission of TB (39; 40).
Health-care workers is a binary variable representing if the patient works/studies in a health
care facility or not. Health-care workers, which are potentially exposed to TB on an every day
basis, are usually considered a high risk group for TB infection and transmission.
Community residence is a binary variable representing whether the patient lives in a commu-
nity residence or not. This variable was included in the analysis, since most of the people living
in a community residence may have lower socio-economic status and there is a high degree
of social interaction, both of which are known risk factors to increase TB transmission and
infection.
Homeless is a binary variable indicating if the patient is homeless or not. Homelessness has
been associated with TB infection.
Transferred is a binary variable representing whether the patient was transfered from another
health institution or not. Both records are used to complement information, however only
the second record (corresponding to the end of treatment) is kept. Information about the
transference if save on this variable. This variable was included in the analysis since stopping
the treatment, although temporarily, can be associated with a higher risk of infection.
Table 2.1: Coding of the variables
Name Description Coding
Vac BCG vaccination 0 - Yes1 - No
CliForm Clinical form of TB 0 - Pulmonary form1 - Extrapulmonary form
Symp Time to diagnosis tuberculosis, in weeks Continuous
Radio Radiology
0 - Normal
1 - Without cavitation
2 - With cavitation
PrevTB Previous TB treatment 0 - First infection1 - Recurrent episode
Sit Patient outcome
0 - Cured
1 - Death
Continue on next page
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Table 2.1 – continued from previous page
Name Description Coding
2 - Default
Treat Duration of treatment, in months Continuous
HIV HIV 0 - No1 - Yes
Diabetes Diabetes 0 - No1 - Yes
NumCo Number of comorbidities
0 - No more diseases
1 - Has one disease
+2 - Has two or more diseases
Sex Gender 0 - Female1 - Male
age Age of the patient Continuous
Origin Country of birth
0 - Portuguese
1 - Low risk country
2 - High risk country
Arrival Number of years in Portugal Continuous
Smk Smoker 0 - No1 - Yes
Alc Alcoholic 0 - No1 - Yes
Unemp Unemployed 0 - No1 - Yes
Drugs Drug dependent 0 - No1 - Yes
Prison Prison 0 - No1 - Yes
Job Health care worker 0 - No1 - Yes
Commu Community residence 0 - No1 - Yes
Hmless Homeless 0 - No1 - Yes
Transf Transfered from another institution 0 - No1 - Yes
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3.1 Understanding and handling missing data
The goal of any statistical analysis is to make valid inferences regarding a population of interest.
A common problem of data analysis is the existence of missing data, which is unavoidable in
epidemiological and clinical research. The way most studies deal with it is to discard the whole
entries with missing information, performing a complete case analysis. In fact, most software
packages automatically exclude individuals with missing observations and perform a complete
case analysis (41). This is not always the most appropriate solution and can lead to inferences
substantially different from those who be would obtained if no data had been missing, and to
a reduction of the statistical power of the analysis. Two other methods which are frequently
used are Mean Imputation (the mean of the observed values is used to replace a missing value)
and Missing Indicator (the missing values are treated as a separate category), but generally
they also lead to biased results (42; 43; 44).
Types of missing data
Firstly, it is important to understand why the data are missing. Rubin (45) classified the
missing data mechanisms into three types: Missing Completely At Random (MCAR), Miss-
ing At Random (MAR) and Not Missing At Random (NMAR).These mechanisms describe
relationships between measured variables and the probability of missing data.
When data are MCAR, missing cases are not different from non-missing cases. Thus, the
probability of missingness of the value of a variable is unrelated to other variables and to their
values, and the missing values are randomly distributed through the dataset. Examples of
MCAR data are when a tube with a blood sample of an individual is accidentally broken or
when a patient questionnaire is lost. In cases like these, individuals with missing values can
be excluded from the analysis and valid inferences obtained, nevertheless, it will still result in
loss of statistical power. The MCAR mechanism is expressed through the formula:
P (R|Z) = P (R|Zobs,Zmis, φ) = P (R|φ) (3.1)
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where Z is a vector of partially observed data, that is, Z = (Zobs,Zmis), R is a set of
response indicators (i.e., Rj = 1 if the jth element of Z is observed, and Rj = 0 if the jth
element of Z is missing), indexed by parameters φ (41; 43; 45; 46; 47).
However, if the missingness of a variable depends on observed values then the missing-data
mechanism is said to be MAR. The MAR assumption is valid if it can be assumed that the
pattern of missing values is conditionally random, i.e. given the observed data, the probability
distribution of R is independent of the missing data. The MAR mechanism is expressed
through the formula:
P (R|Z) = P (R|Zobs, φ) (3.2)
But if the missingness depends on information that has not been recorded, the mechanism is
classified as NMAR or nonignorable (41; 43; 45; 47):
P (R|Z) = P (R|Zobs,Zmis, φ) 6= P (R|Zobs, φ) (3.3)
The majority of studies deals with MAR data and the majority of newly developed software
packages makes the assumption that the data are MAR (43). For instance, for patients
with more severe symptoms, the priority is to perform more tests in order to check for more
serious conditions, whereas patients with mild symptoms are less likely to go through additional
tests and a greater emphasis is given to understand the patient history. Therefore, under
these conditions, perform a complete case analysis will lead to biased estimates of regression
coefficients and overestimation of precision since the subset of complete observations is highly
selected (41). The same scenario is present when the proportion of missing data is large.
Performing a complete case analysis or mean imputation will also lead to biased results since
the sample of complete cases might not be a proper representation of the entire dataset
(42; 44; 48).
Another important concept relates to whether the pattern of missing data is monotone or
nonmonotone. The missingness is monotone when the data matrix can be arranged in a way
to create a hierarchy, i.e., observing a variable Zb for a subject implies that variable Za is
observed for all a < b. A nonmonotone pattern happens when the variables are never observed
simultaneously (46; 49; 50; 51). Figure 3.1 displays two hypothetical datasets. The majority
of the multiple imputation software sorts the data into groups based on whether the variables
are observed or missing.
3.1.1 Complete Case Analysis
Complete case (CC) analysis is also known by listwise deletion. CC consists of omitting cases
with missing data and proceed with the analysis on what remains. However, using CC analysis
is only reasonable, although inefficient, when the subjects with missing data are a random
sample of all the cases, that is under the MCAR assumption. However, even under the MCAR
assumption, one of problem of using CC is that the number of complete observations could be
rather small if many variables are considered. In that case, the problem is that a small dataset
leads to higher standard errors and wider confidence intervals (52; 53).
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Figure 3.1: Monotone and non-monotone patterns of missingness (Obs=observed, M=missing)
(50)
If the data is MAR or NMAR, using CC will lead to biased estimates and loss of efficiency,
power and precision (52).
3.1.2 Mean Imputation
Single imputation is another frequently used method. However, this method treats all values
as observed values, ignoring that some values have been imputed, resulting in small standard
errors (54).
Mean imputation is an unconditional single imputation method, since that for any variable, the
missing value is replaced by the mean or median of the observed values. The term unconditional
refers to the fact that information about the individual is not collected to impute the missing
value. Mean imputation generally results in unbiased estimates but overestimation of the
precision (43; 55).
3.1.3 Multiple Imputation
Multiple imputation is an effective method to deal with missing data and relatively easy to
implement since it is now available in diverse statistical software. However, imputations are
computionally intensive and need to be applied carefully to avoid distortion of estimates and
standard errors. Multiple imputation should not be regarded as a routine technique, the
modelling process should be done carefully and appropriately. A recent study (56) used multiple
imputation to handle the missing data in the dataset. The results of this study suggested that
cardiovascular risk was not associated to cholesterol. Using a complete case analysis, the
authors found a clear association between cardiovascular risk and cholesterol. The reason for
the lack of association between these variables in the imputed dataset was the omission of the
cardiovascular disease outcome in the imputation model and the high proportion of missing
values for HDL (High Density Lipoprotein) cholesterol. Therefore, it is important to be aware
of the problems that an incorrect imputation may bring (54).
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Understanding how multiple imputation works is not very difficult. Multiple imputation is
implemented in three steps: imputing the data, analyzing the data and pooling the results,
sometimes referred as the imputation phase, the analysis phase and the pooling phase, respec-
tively. The first step consists in replacing the missing values by imputed values, thus creating
multiple versions of "complete" datasets without missing values. Multiple imputation is based
on a bayesian approach since the imputed values are sampled from their predictive distribution
based on the observed data. The true values of the missing data are never known, therefore,
in order to account for the uncertainty in predicting the missing values, some variability is in-
cluded into the multiple imputed values. The analysis are run separately on each dataset since
the estimates will differ in each imputation due to the variability introduced. The final step
consists in combining (pooling) the results of multiply imputed datasets using "Rubin’s rules"
(49), which account for the variability between the imputed datasets and generates correct
standard error estimates and coverage rates (54; 55; 57; 58). The estimate of each parameter
(e.g. regression coefficent b) is simply the average of the parameter estimates βm obtained
over the m imputed datasets (m = 1, ..,M):
β∗ = 1
M
M∑
m=1
βm (3.4)
In multiple imputation, the variance of the estimator is partitioned into the within imputa-
tion variance, which captures the sampling variability, and the between imputation variance,
which captures the estimation variability due to missing data (59; 60). The within imputation
variance, Ub, is the average of the squared standard error (SE) of the regression coefficient
estimates over the m imputed datasets.
Ub =
∑ SE2b
m
(3.5)
The between imputation variance, Bb, is the sample variance of the parameter estimates over
the m imputed datasets.
Bb =
1
(m− 1)∑(b− b¯)2 (3.6)
These two variances are combined in order to provide a single variance, given by
Tb = Ub +
[
1 + 1
m
]
Bb (3.7)
Assumptions of the methods
The majority of algorithms for multiple imputation assumes that the data are normally dis-
tributed. Some debate exists around the best way to deal with skewed variables. Some
authors (54; 61) claim that the inclusion of non-normally distributed variables may introduce
bias. Therefore, it is recommended to transform such variables in order to approximate nor-
mality before imputation and then transform the imputed values back. However, recent studies
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by Von Hippel (62; 63) argue against transforming skewed variables since by transforming the
variable to meet the normality assumption, one also changes the distribution of the variable
and the relationship between that variable and the others to impute. Von Hippel claims that
the methods used to transform variables create more bias than imputing the skewed variable.
For a plausible imputation, it is crucial to include as much information as possible. Any variable
that will be in the analysis model should also be in the imputation model. The dependent
variable should also be included since it may contain information about the missing values of
some covariables. Variables with interactions are more complicated to add to the imputation.
Several solutions exists to deal with interactions, in case of an interaction between a binary
variable and a continuous variable, the dataset is divided in two (one dataset for each category
of the binary variable) and the imputation is done separately for each dataset. After the
imputation, the datasets should be combined (61).
Number of iterations and imputations
Recent investigation (55; 64) suggests that a small number of iterations should be sufficient,
usually between 5 to 20 iterations for each imputation. The idea is that after 10 iterations, the
order in which variables were imputed no longer matters since the imputations have stabilized.
Therefore, in this study a total of 10 iterations will be used. Although 10 iterations is not a
large number it will produce accurate results and prevent loss of power.
The traditional approach to select the number of imputations (m) is based on the efficiency
proposed by Rubin (49). The idea is that 2 to 10 imputations are enough since it generates
confidence intervals and hypothesis tests close to their nominal coverage and significance levels.
However, if the fraction of missing information (γ) is large, a larger number of imputations
is needed. The fraction of missing information can be informally described as the quantity of
information lost about each coefficient due to the missing data. The missing data are specific
for each coefficient. In case of multivariate datasets, the fraction of cases with missing values
is not equivalent to the fraction of missing information (57).
Graham et al. (59) compared the effect of different values of γ with different m. When m
was low, the values of mean squared error (MSE) and SE increased, the power of statistical
tests was reduced and the variability of estimates increased. Although statistical efficiency
and power are important, one should also consider the reproducibility of the experiment, this
means considering the Monte Carlo error of the results. The Monte Carlo error is defined as
the standard deviation across repeated runs of the same imputation. With the increase of m
the Monte Carlo error tends to zero (60).
The relative efficiency proposed by Rubin is calculated by:
1
1 + γm
(3.8)
However, this formula assumes knowledge of γ which, most of the times, is unknown. Besides,
Rubin’s method does not address imputation variability (57).
A different approach suggested by Bodner et al. (57) suggests computing a estimated of γ:
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γˆL = 1− nL
n
(3.9)
Where nL = 2890 and n = 8364, where nL correspond to the number of complete cases
without missing information and n correspond to the total number of observations, including
missing observations, therefore:
γˆ = 1− 28908364 = 0.65 (3.10)
This method is conservative since γ would be less than γˆ with this difference increasing with
variables with missing values strongly related to other variables.
Several articles (57; 59; 60) suggests the application of a rule of thumb. m should be at least
equal to the percentage of incomplete cases. For this study 70 imputations will be consider.
The efficiency can be calculated with the estimate of γ :
1
1 + 0.6570
= 0.99 (3.11)
Guidelines for imputation
Although, creating multiple imputed datasets can be computationally demanding, researchers
have much to gain with multiple imputation. With the recent investigation around this topic,
it is no longer excusable to discard the missing values and use only a complete case analysis.
To avoid pitfalls, Sterne et al. (54) mention some guidelines to follow when presenting papers
or reports about missing data. These are useful suggestions and all will be followed through
this thesis.
∗ Mention the number of missing values or the number of complete cases for each variable.
Try to interpret why these values are missing.
∗ Compare the distributions of variables for individuals with complete and incomplete data.
∗ Describe the methods used to deal with missing data and the assumptions made, i.e.
type of missing data, etc. Provide details of the imputation technique as well as details
about the software used.
∗ Mention the number of imputations used and the reason for that number.
∗ List the variables used in the imputation and their characteristics, i.e. normally dis-
tributed, binary, interactions etc, and how these variables were handled.
∗ In studies with a large amount of missing data, compare observed and imputed values.
∗ When possible, include results from complete case analysis and compare with the results
obtained with multiple imputation, discussing the differences (if any is present) and
suggest ideas about these differences.
∗ Discuss the plausibility of MAR assumption and whether the variables included in the
imputation follow this assumption.
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3.1.3.1 Multivariate Imputation by Chained Equations (MICE)
MICE, also known as Fully Conditional Specification(FCS), is one of the approaches used to
impute multivariate data. MICE is a flexible method, that does not rely on the assumption of
multivariate normality. The multivariate imputation model is specified on a variable-by-variable
basis by a set of conditional densities, one for each incomplete variable. This approach is
adequate since it does not restrict conditional distributions to being normal.
Let Yj = (j = 1, ..., p) be one of p incomplete variables, where Y = (Y1, ...Yp). Let Y−j =
(Y1, ..., Yj−1, Yj+1, ..., Yp) denote the collection of p − 1 variables in Y except Yj . Let the
hypothetically complete data Y be a partially observed random sample from the p-variate
multivariate distribution P (Y |θ). Assuming the multivariate distribution of Y is completely
specified by θ, a vector of unknown parameters. The chained equations proposes to obtain a
posterior distribution of θ by sampling iteratively from conditional distributions of the form:
P (Yp|Y−p, θp) (3.12)
The parameters θp are specific to the conditional density. The ith iteration consists of succes-
sive draws of the Gibbs sampler:
θ∗(i)p ∼ P (θp|yobsk , y(i)1 , ..., y(i)p−1)
y∗(i)p ∼ P (yk|yobsk , y(i)1 , ..., y(i)k , θ∗(i)k )
(3.13)
where Y (i)j = Y obsj , Y
∗(i)
j is the jth imputed variable at interation i. Iterations of equation
(3.13) are executed m times to generate m imputations.
The Multivariate Imputation by Chained Equations was implemented through the package
mice (61). Figure 3.2 illustrates the steps involved in multiple imputation: imputation, analy-
sis and pooling. First, the variable with least missingness is imputed conditional on all variables
with no missing values, the variable with the second least missingness is then imputed condi-
tional on the variables without missing values and the imputed variable, until all variables have
been imputed. This process is repeated for x iterations. Each of the m imputed datasets will
have distinct imputed values. The magnitude of the difference reflects the uncertainty about
the missing value. The second step consists in analysing the data to estimate the parameter
of interest. After the analysis, the results are pooled using Rubin rules (49; 55), obtaining a
single estimate for the parameter of interest.
Several problems may arise when dealing with multivariate data: variables could be correlated
with each other, they may be of different types (some binary, continuous, ordinal, etc), relations
between variables could be complex (for instance in cases of censoring data), etc. To address
these issues, it is convenient to specify the imputation model separately for each column in
the data. The name chained equations refers to the fact that the Gibbs sampler can be
implemented as a concatenation of univariate procedures to impute the missing data (61).
Imputation models Van Buuren (61) specifies some rules in order to perform the most
accurate imputation.
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Figure 3.2: Schematic approach of the mice algorithm (61)
∗ Explore the data in order to understand what type of missing data is present, MCAR,
MAR or MNAR. The package mice handles MAR and MNAR data.
∗ The second concern should be the form (structural part and error distribution) of the
imputation. The form has to be specified for each column with missing data.
∗ When imputing missing values it is recommend to use as many variables as possible; in
fact, adding ’auxiliary variables’ related to the missingness strenghten the MAR assump-
tion (55). mice has a function to easily specify the set of predictors to be used for each
incomplete variable.
∗ The fourth point relates to the form of variables. If any of the variables needs a tran-
formation, if any interaction term is present, etc.
∗ Another aspect to consider is the order by which the variables are imputed. Within mice
it is easy to change the order.
∗ An important consideration is the number of iterations that should be between 5 to 20.
∗ In what concerns the number of imputed datasets (m), setting m too small lead to low
p-values.
For every distinct dataset, these points should be checked and carefully chosen to originate an
accurate imputation model.
3.1.3.1.1 Predictive Mean Matching (PMM)
PMM is a semi-parametric imputation method, developed by Little (65). This method com-
bines elements of regression, nearest-neighbour and hot deck imputation. The basic concept
of PMM is to impute a missing value by matching its predictive mean to a nearest neighbor
among the predictive means of the observed values, and to adopt the actual observed value.
A regression model is estimated where the dependent variable is the variable to impute and
the remaining variables act as independent variables. A value for the dependent variable is
estimated for individuals with missing data. The predicted value of the dependent variable
is matched with the nearest fitted value, calculated through euclidean distance. Let yi be a
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value of a variable Y , with i = 1, ..., n where only units 1, ..., nobs are observed. Let yˆi be a
predicted value from a regression of Y on some explanatory variables. The euclidean distance
between yˆi and yˆj is given by
Di,j = |yˆi − yˆj | (3.14)
and yobs,j is imputed for ymis,i (66). The observed value corresponding to the nearest fitted
value is imputed. If more than one fitted value has equal distance to the minimum distance
found, the value to impute is randomly chosen between those that were tied.
By imputing observed values, PMM only gets plausible values for the imputed data which is an
advantage since the range and shape of distribution is preserved. This method is complicated
when imputing a categorical variable with more than 2 levels, like Radio and Origin.
3.1.3.1.2 Random Forest (RF)
A decision tree is a tree with thresholding nodes (continuous variables) or categorical nodes
(categorical data), which contains information about the attributes in the input vector. The
information is used to follow a decision path. Random Forest is an extension of classification
and regression trees, that uses ensembles of decision trees. A powerful advantage of RF is
that it does not rely on distributional assumptions and works well with nonlinear relations and
interactions. In fact, a previous study (67) compared the performance of several methods
applied to datasets with interactions between variables and the imputation using mice with
RF resulted in less biased paramater estimates.
To impute missing values, the algorithm inaccurately fills the missing values, then performs a
forest run and computes proximities. In case of a continuous variable, the value is estimated
as the mean over the observed values of the yth variables weighted by the proximities between
the nth case and the observed value. In case of a categorical variable, the missing value is
replaced by the most frequent value weighted by proximity. Iterate a new forest using the
previously imputed values to impute new values and iterate.
If two trees are highly correlated in the forest, the forest error rate will increase. A tree with a
high error rate is a low classifier. Increasing the strength of each individual tree will decrease
the forest error. A low value of m reduces both the correlation and the strength. During
each run, the out-of-bag (OOB) error is estimated. Each tree is constructed with a different
bootstrap sample from the dataset. About one third of the cases are not used in the bootstrap
sample. For each case not used in the construction of the kth tree, put it down the kth tree to
get a classification. In that sense, a test set classification is obtained for each case in about
one-third of the trees. At the end, let j be the class with most votes every time case n was
OOB. The OOB error estimate corresponds to the proportion of times that j is not equal to
the true class of n, averaged over all classes (68; 69).
Rather than taking random draws from a distribution, the package missForest aims to predict
individual missing values. This may lead to biased parameter estimates (70). Whereas the
method implemented in mice imputes values by randomly drawing values from independent
normal distributions centered on conditional means (61).
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The OOB error rate can be used to determine the number of trees. Although, a large number
of trees will lead to better results this also lead to a huge computational time. Therefore, the
number of trees was set to 25, since the OOB error seems to be quite small already (figure
3.3).
Figure 3.3: Variation of OOB error with the increase in the number of trees
3.1.3.2 Expectation-Maximization with Bootstrapping (EMB)
To implement the EMB algorithm, the package Amelia II was used. Amelia II uses the
EM algorithm on multiple bootstrapped samples of the incomplete dataset to estimate values
and replace the missing values by these estimated values. First, the EM algorithm is briefly
explained.
Expectation-Maximization (EM)
The Expectation-Maximization (EM) algorithm, proposed by Dempster, Laird and Rubin (71),
is an approach to the iterative computation of maximum likelihood (ML) estimates, useful in
a variety of incomplete-data problems, either because the values were not reported, or due to
the impossibility of direct observation of these values.
First, a distribution and the starting values for the mean and variance are assumed. Using
these simulated values, an expected value of model likelihood is calculated, the likelihood
is maximized, model parameters are estimated that maximize these expected values and the
distribution is updated. The process is repeated until the values converges.
Let X be a set of observed data, Z a set of missing values and θ a vector of unknown
parameters. The log likelihood function to estimate θ
L(θ;X) = P (X|θ) =
∑
Z
P (X,Z|θ) (3.15)
The ML estimate of the unknown parameters is determined by the marginal likelihood of the
observed data.
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Each iteration consists of two steps: the E-step (Expectation-step) and the M-step (Maximiza-
tion step). In the E-step, the missing data are estimated given the observed data and current
estimate of the model parameters.
Q(θ|θ(t)) = EZ|X,θ(t) [logL(θ;X,Z)] (3.16)
In the M-step, the likelihood function is maximized under the assumption that the missing
data are known using the estimate obtained in the E-step (formula 3.17). In summary, EM
attempts to find the estimates θˆ that maximizes the log probability (x; θ) of the observed data
(72; 73).
θ(t+1) = arg max
θ
Q(θ|θ(t)) (3.17)
Expectation-Maximization with Bootstrapping (EMB)
Figure 3.4 represents how the EMB algorithm works. First non-parametric boostrap is applied
to the incomplete dataset in order to obtain boostrap subsamples of size n (sample size = n)
to be drawn of the incomplete dataset m times (in this case, m = 5). The EM algorithm is
applied to each one of the bootstrap subsamples. The analysis is performed in each one of the
imputed subsamples and the results are pooled using Rubin’s rules.
Figure 3.4: Schematic approach of the EMB algorithm (74)
The imputation model in Amelia II assumes that the complete data is multivariate normal,
although this is often a crude approximation to the true distribution of the data. An interesting
feature of Amelia II is that the multivariate normal model works well even when variables are
discrete or non-normal. Like the majority of multiple imputation methods, Amelia II assumes
that the data are MAR (74; 75).
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3.1.4 Comparison between methods
To compare the models fitted to imputed datasets several features were compared. Among
them the variables that each model selected, the direction of the estimate of the coefficients,
the absolute value and standard error of the estimate of the coefficient, as well as the p-value
associated with the corresponding test. The width of the CI was assessed for each model, since
a smaller CI means that the estimate of the true effect is more precise. To validate each model,
some measures were used. The R2 of Nagelkerke represents the amount of variability explained
by the covariates included in the model. Another measure used is the index of concordance,
the C index, which is used to evaluate the power to discriminate between individuals with
different responses. The time of execution for each imputation is also reported. The values of
the statistic −2 log Lˆ was used to compare models fitted to the same data.
3.2 Survival Analysis
3.2.1 Basic Concepts of Survival Analysis
Survival analysis is an area of Statistics taht was developed to analyse data representing times
from a time origin until the ocurrence of the event of interest. In medical research, the time
origin is often the time of recruitment into a clinical trial or study. Although, the event of
interest can be the death of the patient, recurrence of symptoms or any other particular event,
the event of interest is usually named death and the time since the time origin until the event
of interest is named survival time.
One of the reasons why standard statistical procedures do not apply to this type of data is
that survival times are generally not symmetrically distributed. In fact, survival times tend to
be positively skewed, therefore it is inadequate to assume a normal distribution. However, the
most important feature of survival data is the existence of censored observations (76; 77).
Censoring
Censoring is present when for some individuals the event of interest is not observed during
the time of observation. Although these individuals only have partial information about their
survival time, they should be included in the analysis, otherwise there will be loss of information.
Right censoring happens when the event of interest has not been observed for an individual
when the study ends. This may be because the event of interest occurs after the end of the
study, or the patient may have been lost to follow-up. The right-censored time is less than
the actual, yet unknown, survival time. Right censoring can be classified into censoring type I,
censoring type II and random censoring. Right censoring type I occurs when the observation
times are fixed by the researcher. The number of deaths is random. However, if the number
of deaths is not random, i.e., the study ends when r deaths are observed the study presents
right censoring type II. r is a fixed number, smaller than the total number of individuals. The
most common type of right censoring is the random censoring. In medical research, usually
individuals enter the study randomly, according to the diagnosis date or another important
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time origin. If the study ends at a fixed date, the time since the time origin until the end of
the study is random.
Opposite to right censoring, left censoring happens when the real survival time is less than the
observed time. Left censoring occurs less frequently than right censoring. A good example of
left censoring is when the researcher intends to study the age that a child performs a given
task. However, some children may already perform the task when entering the study, therefore
the observations are left censored since the recorded value will be the age of the child at the
beginning of the study. Another type of censoring is interval censoring. In this case, individuals
are known to have experienced an event within a certain interval of time.
The individuals censored at time t must be representative of all individuals that survived until
t. At any time, individuals can not be selectively censored, either because their risk of death
is high or low, i.e., censoring is not related to the event of interest. This is known as non-
informative censoring, necessary to validate the methods usually used in survival analysis. This
hypothesis is usually true in case of censorship that occurs at the end of the study → random
right censorship. Non-informative censorship is also known as independent censorship (76).
Survivor function and Hazard function
Let T be a positive continuous random variable that represents the survival time of an in-
dividual, i.e., the time until the ocurrence of the event of interest. The survivor function is
defined as the probability that an individual survives beyond the time t (3.18). This function
is continuous and monotonically decreasing.
S(t) = P (T > t), t ≥ 0 (3.18)
The probability density function is given by
f(t) = lim
∆t→0+
P (t ≤ T < t+ ∆t)
∆t = −S
′(t) (3.19)
The distribution of T can also be characterized by the hazard function (3.20). This function
describes the risk or hazard of death at some time t, and is obtained from the probability that
an individual dies at time t, conditional on having survived to that time.
h(t) = lim
∆t→0+
P (t ≤ T < t+ ∆t|T ≥ t)
∆t (3.20)
The function h(t) is also referred to as the hazard rate, the instantaneous death rate, the
intensity rate or the force of mortality. From equation (3.20), h(t)∆t is the approximate
probability that an individual dies in the interval (t, t+ ∆t), conditional on that person having
survived to time t.
The function H(t), called integrated or cumulative hazard, is defined by
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H(t) =
∫ t
0
h(u)du, t ≥ 0 (3.21)
These functions are related and can be obtained from each other. Some useful relationships
are the following:
S(t) = 1− F (t)
h(t) = −∂ ln(S(t))
∂t
h(t) = f(t)
S(t)
H(t) = − ln(S(t))
S(t) = exp(−H(t))
(3.22)
3.2.2 Non-parametric Inference
Kaplan-Meier Estimator
In the absence of censoring, the survivor function at a given time t is estimated by the proportion
of individuals that survived beyond the time t, i.e., with observed survival times greater than
t. This estimator is the empirical survivor function, given by
Sˆ(t) = Number of individuals with survival times > tNumber of individuals in the dataset (3.23)
However, this method cannot be used when there are censored observations. Kaplan and Meier
(78) proposed a non-parametric estimator of the survivor function in the presence of censored
observations. Denote t(1), ..., t(r) the r distinct times where the deaths occurred in a sample
of size n(r ≤ n), di the number of deaths occurred in t(i) and ni the number of individuals
at risk at t(i). The Kaplan-Meier estimator of the survivor function is given by
Sˆ(t) =
∏
i:t(i)≤t
ni − di
ni
=
∏
i:t(i)≤t
(
1− di
ni
)
(3.24)
with Sˆ(t) = 1 when 0 ≤ t < t(1). If the largest observation is not censored Sˆ(t) = 0 for
t ≥ t(r). However, if the largest recorded observation t∗ is censored, then Sˆ(t) will never reach
0 and it is considered that the estimate is defined only until that time. When a death time
and a censored survival time are registered with the same value, it is assumed that the death
precedes the censoring.
The estimated variance of Sˆ(t) is known as Greenwood’s formula:
v̂arSˆ(t) = [Sˆ(t)]2
∑
i:ti≤t
di
ni(ni − di) (3.25)
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A confidence interval can be obtained for the survivor function at a given time t, based on that
the estimator of the survivor function has asymptotic normal distribution with mean value S(t)
and estimated variance v̂ar[Sˆ(t)]. A 100(1 − α) confidence interval for the survivor function
at time t is given by
Sˆ(t)± z1−α2
√
v̂ar[Sˆ(t)] (3.26)
where zα is the α percentile quantil of the N(0, 1) distribution.
Given that the distribution of the survival time is generally positively skewed, the median is
the usual summary measure of location. Once the survivor function has been estimated, an
estimate of the median, tˆ(50), is given by
tˆ(50) = min{ti : Sˆ(ti) ≤ 0.5} (3.27)
being ti the ith ordered death time, i = 1, 2, ..., k. The median estimate is the smaller observed
survival time for which the estimate of the survivor function is smaller or equal to 0.5, i.e.,
the time beyond which 50% of the individuals in the population under study are expected to
survive.
The Kaplan-Meier method allows to compare survival curves of different groups. The total of
observations is divided in groups or strata (k groups), according to the covariables of interest
and the survivor functions are estimated separately for each strata. It is usual to plot the
estimates of the k survivor functions on the same axes. There are two possible explanations
for an observed difference between two estimated survivor functions. One is that there is a
real difference between the survival times of the two groups. The other is that there are no
real differences and that the observed difference is only due to chance variation (76; 77; 79).
To compare the survivor functions some non-parametric tests are used, which are named rank
tests, since the test statistic depends only on the order of the observations. Thus, evaluating
if significant differences in survival exists between the groups. In this thesis, the log-rank test
and Peto-Peto test were used since both were available in R. The null hypothesis of these tests
is that there are no difference between groups
H0 : S1(t) = S2(t) = ... = Sk(t) vs H1 : ∃(i,j)Si(t) 6= Sj(t) (3.28)
being k the number of strata.
Log-rank test
Based on the work of Mantel and Haenszel (80), Mantel (81) proposed a test designated by
log-rank or Mantel-Haenszel test. Consider two groups (1 and 2) with sample sizes m and n,
respectively. Let t1 < t2 < ... < tk be the k distinct death times regarding m+ n individuals.
nij individuals are at risk in group i, (i=1,2), just before tj , and at that instant d1j individuals
of group 1 and d2j individuals of group 2 suffered the event, for j = 1, 2, ..., k. dj = d1j + d2j
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is the total number of events in the two groups from the total nj = n1j + n2j individuals at
risk at time tj . The information can be summarized in a 2x2 contingency table:
Group Number of events Number of survival Number individuals at risk,in tj beyond tj in tj
1 d1j n1j − d1j n1j
2 d2j n2j − d2j n2j
Total dj nj − dj nj
Assuming the null hypothesis is true, the distribution of d1j , conditional to the marginal values,
is hypergeometric
p(d1j |dj , nj) =
(
dj
d1j
)(
nj − dj
n1j − d1j
)
(
nj
n1j
) (3.29)
Under H0, the mean value of d1j is given by
e1j =
n1jdj
nj
(3.30)
which represents the expected number of individuals who experience the event at tj in group
1. The conditional variance of d1j is given by
v1j =
n1jn2jdj(nj − dj)
n2j (nj − 1)
(3.31)
To obtain a global measure of the deviation of the observed values of d1j from their expected
values consider the statistic:
U =
k∑
j=1
(d1j − e1j) (3.32)
where U is the difference between the total observed number and expected number of events
in group 1. This statistic presents E(U) = 0 since E(d1j) = e1j . Since the death times are
independent, the variance of U is the sum of the variances of d1j
var(U) =
k∑
j=1
v1j (3.33)
The test statistic proposed by Mantel and Haenszel is expressed by
Q = U
2
var(U) (3.34)
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with an asymptotic χ21 distribution, under H0.
Peto-Peto test
Another non-parametric test used to compare survivor functions is the Peto-Peto test proposed
by Peto and Peto (82). This test is a generalization of the Mann-Whitney-Wilcoxon test in
the presence of censored observations, with the statistic:
U =
k∑
j=1
wj(d1j − e1j) (3.35)
The difference between this statistic and the one from the log-rank test (3.32) is in the weight
associated with each difference (d1j − e1j). While in the log-rank test this weight is equal to
1, the weight in the Peto-Peto test is wj = Sˆ(tj), where Sˆ(tj) corresponds to an estimate of
the survivor function given by
Sˆ(tj) =
∏
ti≤tj
(
1− di
ni + 1
)
(3.36)
which is similar to the Kaplan-Meier estimator for the joint sample.
3.2.3 Cox Regression Model
A parametric regression model requires a probability distribution for the survival time. If that
assumption is not adequate the model can produce incorrect parameter estimates. However,
most of the times, the interest centres on the risk or hazard of death at any time and not on
the parameters of the distribution. In this case, the goal is to determine which combination
of potential variables affect the form of the hazard function. The most frequently used model
in this case is the proportional hazards model. This model was proposed by Cox (83) and
is also known by Cox regression model. The model is referred as a semi-parametric model
since no particular form of the distribution is assumed for the survival time; it is based on the
assumption of proportional hazards.
Formulation of the proportional hazards model
Let T be a continuous random variable representing the survival time. At time t and for an
individual with vector of covariates z = (z1, ..., zp)′, the hazard function is given by
h(t; z) = h0(t)exp(β′z) (3.37)
where β is a vector of regression coefficients that represent the effect of the covariates on
survival. h0(t) represents the baseline hazard function for an individual to whom is associated
a vector z = 0.
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It is a proportional hazards model since the hazard functions corresponding to two individuals
with covariates z1 and z2 are proportional.
h(t; z1)
h(t; z2)
= exp{β′(z1 − z2)} (3.38)
This formulation implies that the covariates have a multiplicative effect on the hazard function,
that is, the hazard ratio is constant over time (76; 77; 79).
Interpretation of parameters estimates
In fact, usually, exp(βj) is preferred over βj , since exp(βj) provides a straightforward inter-
pretation regarding the risk of death. exp(βj) represents the relative risk of ocurrence of the
event of interest for two individuals that differ in one unit in the values of the covariate zj ,
with the values of the remaining covariates being equal.
Consider a binary covariate defined by z = 0 if the individual belongs to group 1 and z = 1 if the
individual belongs to group 2. When the individual belongs to group 1 then h(t; z = 0) = h0(t)
and when the individual belongs to group 2 then h(t; z = 1) = h0(t) expβ.
◦ If β < 0⇔ expβ < 1, patients in group 2 have better prognosis than patients in group
1;
◦ If β > 0⇔ expβ > 1, patients in group 1 have better prognosis than patients in group
2;
◦ If β = 0⇔ expβ = 1, patients in groups 1 and 2 have a similar prognosis.
In the case of a numeric covariate:
expβ = h(t; z = j + 1)
h(t; z = j) (3.39)
For instance, if z corresponds to the age of a patient, expβ represents the risk of death of a
patient with a certain age compared with a patient one year younger. The hazard ratio for a
patient aged 50 relative to one aged 49 is the same as that for an individual aged 80 relative
to one aged 79. The hazard ratio does not depend on the actual value of the covariate.
Likelihood function
The βj ’s coefficients are estimated using the method of maximum likelihood. Consider n
individuals with k observed survival times, t(1) < ... < t(k), k < n. The set of individuals who
are at risk at time t(i) will be denoted by R(t(i)), so that R(t(i)) is the group of individuals
who are alive and uncensored at a time just prior to t(i) and is called the risk set.
Ri = R(t(i)) = {j : tj ≥ t(i)} (3.40)
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The likelihood function, proposed by Cox (83), for the proportional hazards model is given by
L(β) =
k∏
i=1
exp(β′z(i))∑
l∈Ri exp(β′zl)
(3.41)
where zi is the vector of covariates associated with the individual who dies at the ith ordered
death time, t(i). The summation in the denominator of this likelihood function is the sum
of the values of exp(β′z) over all individuals who are at risk at time t(i). The product is
taken over the individuals for whom death times have been recorded. Individuals for whom the
survival times are censored do not contribute to the numerator of the log-likelihood function
but they do enter into the summation over certain risk sets. Moreover, the likelihood function
depends only on the ranking of the death times. This likelihood function can be seen as
a partial likelihood since this function does not depend of the baseline hazard function and
allows inference on β, without any restriction regarding the form of h0(.) At each time t, only
the information about the individuals at risk is considered. This formulation is similar to the
non-parametric methods but allows an estimation of the effect of the covariates on the survival
time. Under general conditions, it verifies the properties of maximum likelihood estimation. βˆ
is consistent, asymptotically normal with mean value β and covariance matrix I(β)−1, where
I(β) is the Fisher information matrix:
−
[
E
(
∂2 logL
∂βj∂βk
)]
pxp
In case of simultaneous deaths or when the data is not recorded properly yielding equal values,
the function (3.41) cannot be implemented. In this situation, for the n individuals in the study,
suppose that the distinct death times were observed t1 < t2 < ... < tk. Denote di as the
number of deaths occurred at time ti and zij the vector of variables associated to individual
j, that dies in ti, j = 1, ..., di, i = 1, ..., k. If di is small, compared with the number of
individuals in the risk set Ri, then the partial likelihood function can be approximated by the
function, proposed by Peto and Peto (82) and Breslow (84).
L(β) =
k∏
i=1
exp(β′si)
[∑l∈Ri exp(β′zl)]di (3.42)
where si =
∑di
j=1 zij , for i = 1, ..., k. This is the likelihood usually implemented in software
packages. If the observations do not have ties, the function (3.42) reduces to the partial
likelihood (3.41) (76; 77; 79).
Variable Selection
The first step in the model selection process is to identify a set of potential explanatory vari-
ables, in order to understand which ones have a significant impact on survival of the individuals.
As previously discussed, βj represents the effect of the covariate zj on the survival of the in-
dividual. To evaluate the existence of evidence that the covariate significantly influences the
survival time, one can test
H0 : βj = 0 vs H1 : βj 6= 0
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using the Wald test, where the test statistic βˆ2j /var(βˆj) has, under H0, an asymptotical χ21
distribution. The null hypothesis tested is that the covariate zj does not have a significant
influence, in the presence of the remaining variables, in the survival. However, the estimates
βˆ are not all independent which difficults the interpretation of the results. Therefore, it is
preferred to compare alternative models.
In order to find a model, without unnecessary variables, a range of automatic routines are
implemented in several software packages, based on forward selection, backward elimination
and a combination of the two, known as stepwise procedure. However, these automatic routines
have a number of disadvantages. They lead to the identification of one subset of variables,
instead of a set of equally good ones. The subset found often depends on the type of variable
selection process used (forward selection, backward elimination or stepwise procedure) and on
the stopping rule used to determine whether a term should be included or excluded from a
model. Instead of using automatic routines, a strategy for model selection, proposed by Collett
(77), was implemented. Collett uses the statistic −2logLˆ to compare alternative models, where
Lˆ is the maximised likelihood under a certain model.
First, a model with each variable is fitted individually. The values of −2logLˆ are calculated for
each model and compared with the value for the null model (without variables) to determine
which variables significantly reduce the value of the statistic, on their own.
In the second step, the significant variables from the previous step are fitted together in a model
and the value of −2logLˆ is calculated. In the presence of certain variables, others may cease to
be important. At each time, a variable is omitted and the value of −2logLˆ is computed. The
variables that do not significantly increase the value of −2logLˆ, when omitted, are discarded.
Every time a variable is dropped the effect of omitting each of the remaining variables should
be examined. Only the variables that significantly increased the value of −2logLˆ are kept in
the model.
Variables that, when examined on their own, were not important and therefore were not
included in the model in the second step, may become important in the presence of others.
These variables are included in the model and if any of them significantly reduce the value of
−2logLˆ they are retained.
To conclude, a final check is performed to make sure that each of the variables present in the
final model, when omitted, significantly increases the value of −2logLˆ and that no variable
not included significantly reduces the value of −2logLˆ.
When using this procedure, a rigid significance level should be avoided. A level of around 10
% is recommended (76; 77).
3.2.4 Residual Analysis
In linear regression, a residual is the difference between the observed value of the response
variable and the predicted value by the model. However, the existence of censored observations
and the form of the Cox regression makes the definition of residual harder and less straight-
forward. A number of residuals have been proposed for use with the Cox regression model.
Disadvantages of the Cox-Snell residuals and deviance residuals are that they depend heavily
on the observed survival time and require an estimate of the cumulative hazard function. These
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disadvantages have been overcome by a residual proposed by Schoenfeld (85). In this thesis,
the Schoenfeld and martingale residuals will be used.
Schoenfeld Residuals
This type of residuals was proposed by Schoenfeld (85) and they are very useful to evaluate the
assumption of proportional hazards. These residuals differ from the Cox-Snell, martingale and
deviance residuals in a way that there is not a single value of the residual for each individual,
but a set of values, one for each explanatory variable included in the fitted Cox regression
model.
For the ith individual, the Schoenfeld residual corresponding to the covariate zj , j = 1, ..., p,
is expressed by
rij = δ{zji − aji}
where δi = 1 if ti is a non censored observation and δi = 0 if ti is a censored observation and
aji =
∑
l∈Ri zjlexp(βˆ′zl)∑
l∈Ri exp(βˆ′zl)
(3.43)
For an individual whose survival time was censored, these residuals are always zero. These
residuals are usually indicated as missing values to distinguish them from residuals genuinely
identical to zero. For an individual whose death was observed at ti, the residual is the difference
between the zj , corresponding to the ith individual, and a weighted average of the values of
that variable for all individuals at risk at ti (76; 77; 79).
Grambsch and Therneau (86) proposed a version of these residuals which is more effective in
detecting departures from the assumed model. These residuals are named scaled Schoenfeld
residuals and are implemented in the survival package of R. Denote ri = (r1i, r2i, ..., rpi)′
the vector of Schoenfeld residuals associated to the ith individual. The scaled Schoenfeld
residuals, r∗ji, are expressed by
r∗i = k x var(βˆ)ri (3.44)
where k is the number of observed deaths among the n individuals and var(βˆ) is the covariance
matrix of the parameter estimates βj in the Cox model fitted to the data (76). A plot of the
scaled Schoenfeld residuals against the survival times allows to verify if the residuals are equally
distributed along the time. If the hypothesis of proportionality of risks is satisfied it should not
exist a systematic trend. The interpretation is easier when one adds a line, such as a spline, to
better visualize the trend. A spline is a smooth non-parametric function, which draws a line
that carries the points density. Besides the visual analysis, it is possible to test the existence of
linear correlation between the time and the residuals. Under the null hypothesis, of correlation
equal to zero, the test statistic has a χ21 distribution. If the null hypothesis is not rejected, the
assumption of proportionality of risks is sustained (79). The test for each covariate is based
on a regression
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βk(t) = βk + θkUk(t), k = 1, ..., p (3.45)
where θk is the variation in time parameter. The null hypothesis is that θk = 0.
Martingale Residuals
The martingale residuals are very helpful in determining the functional form of the covariates
as well as detecting outliers.
When all the variables are fixed, at the beginning of the study, the martingale residual associ-
ated to the ith individual, i = 1, ..., n, is given by
Mˆi = δi − exp(βˆ′zi)Hˆ0(ti) (3.46)
where δi is the indicator variable, Mˆi represents the difference between the observed number
of events for the ith individual in the interval (0, ti), and the corresponding expected number,
estimated based on the fitted model. In fact, the number of expected deaths is one if the
time ti is not censored and zero if ti is censored, i.e., equal to δi. ri is an estimate of H(ti),
which can be interpreted as the expected number of deaths in (0, ti) since only one individual
is considered.
These residuals are characterized by great assymetry and values in the interval (−∞, 1), where
the negative values corresponds to the residuals for the censored observations. In large samples,
the residuals are not correlated and have an expected value equal to zero, when calculated for
the true (unknown) vector of β parameters, ∑ni=1 Mˆi = 0.
The analysis of the martingale residuals will reveal poorly adjusted individuals, i.e., individuals
that died too soon or too late, compared with other individuals with similar characteristics.
These individuals are designated outliers. To detect its existence, a visual representation of
the residuals against the index of each individual is made.
The graphic representation of the residuals against a covariate indicates if the functional form
of the covariate is appropriate or if the functional form should be transformed. The simplest
approach consists in representing in a plot the martingale residuals of the fitted null model
(without covariates) against the values of each one of the covariates included in the model.
To facilitate the interpretation of the plot, a smooth curve is added, usually a curve obtained
by LOWESS (Locally Weighted Scatterplot Smoother). If the correct model for the covariate
zj is exp(f(zj)βj) for some smooth function f , then the LOWESS curve for the covariate zj
will show the form of f . If the curve is linear, no transformation is needed (76).
3.2.5 Collinearity
When at least one of the predictors can be predicted by the remaining, the standard error of
the coefficient estimates can be inflated, reducing power to the corresponding tests. On the
other hand, collinearity difficults to estimate and interpret parameters, since the data has few
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information about the effect of changing one variable keeping other variable, highly correlated,
constant.
One way to test the existence of collinearity is through VIF (Variance Inflation Factor). VIF is
defined as
1
(1−R2i )
where R2i is the squared coefficient of multiple correlation between the variable i and the
remaining variables. VIF provides information about how much larger the standard error is,
compared with what it would be if that variable was uncorrelated with the other predictor
variables in the model. Values below 10 are an indication of no problem of collinearity (87).
3.2.6 Measures of explained variation
The proportion of variation in a response variable that is explained by a fitted model is often
used in statistial modelling to summarise the fit of the model. A number of measures of
explained variation have been proposed for use in modelling survival data however, no particular
statistic can be recommended for general use. Moreover, few of these options are implemented
in software packages.
One global measure that evaluates the fit of a model informs about the proportion of variation
explained by the covariates. R2 can be given by
R2 = 1− exp
(
2(logL(0)− logL(βˆ))
n
)
(3.47)
where L(0) is the likelihood function of the null model and L(βˆ) is the likelihood function
of the fitted model. R2 can be interpreted as the explanatory power of the covariates in
the survival time. In survival analysis, the values of R2 are small. Values for the explained
variability below 0.5 are common. Obtaining values of 1 ou close of 1 are unsual since that
would mean that the model has predicted the exact time until the ocorrence of the event for
each individual.
Another useful measure is the index of concordance C. This measure is used to evaluate the
discriminatory power and the predictive accuracy of the Cox model. Concordance implies that,
when randomnly selecting two observations, the one with smaller survival time is also the one
with smaller estimated risk by the Cox model.
3.3 Software
The statistical analysis was performed using R, version 3.1.0 (88).
An appendix with the relevant code to perform this analysis is provided. The aim is to briefly
describe the R code used, including function of libraries available on CRAN (The Comprehensive
R Archive Network).
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Chapter4
Evaluation of risk factors for time to
recurrence
4.1 Exploratory Analysis
In Portugal, between 1 January 2002 and 31 December 2009, 9882 persons were diagnosed
with TB. However, in 1127 cases this was not the first episode of disease and therefore they
were eliminated from this analysis. Of the remaining 8755 individuals, 391 died during the
first treatment and were excluded since the initial date considered, in this study, is the end of
the first treatment. The final dataset consists of 8364 individuals.
All cases
The number of cases of TB per year seems to follow a steady slight increase, with 2008 being
the year with more new cases of TB, as seen in figure 4.1. One of the reasons for the decrease
in 2009 could be the lack of data. Perhaps the system was not updated on time and therefore,
not all individuals diagnosed in 2009 were in the database.
Patients were aged between 0 and 100 years at the end of the first treatment. More than 75%
of the individuals have between 20 and 60 years old. Less than 1% are children with less than
10 years or elders with more than 90 years. Figure 4.2 represents the distribution of the age
of the individuals.
For the period studied, the mean age is 43 years and the median is 40 years. For males the
median age is 42 years and for females is 35 years, as shown in figure 4.3.
The majority of the patients (89%) was born in Portugal, while 10% were born in a high-risk
country, such as Angola, Brazil, Cape Verde, China, South Africa, Mozambique, etc. Figure
4.4 represents the number of years that immigrants have been living in Portugal before being
diagnosed with TB. Of those, 42% were diagnosed on the first year, which could be a sign that
they were infected in their home countries, since the latency period before presenting active
disease is around two years.
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Figure 4.1: Number of cases diagnosed between 2002 and 2009
Figure 4.2: Distribution of the age of all the individuals
Figure 4.3: Boxplot of age according to gender
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Figure 4.4: Distribution of the number of years immigrants have been living in Portugal
More than half of the individuals (51%) have at least one of the considered risk factors (health
care job, alcoholism, smoking, drug problem, in prison or community residence, homeless,
unemployed or has HIV or diabetes).
There is a higher proportion of males with TB than females. Table 4.1 explores this difference
by showing the number of cases in each category of the variables representing the risk factors
that were considered. The amount of missing information is also displayed in this table. For
each risk factor considered, the main idea is to compare the proportion of individuals that
belong to the category "Yes" with the proportion of individuals with missing information, for
each gender.
Less than 3% of the individuals are health care workers, however this information is missing for
almost 10%. Through table 4.1 it is possible to see that, among health care workers, almost
60% are female. Around 10% to 15% are either alcoholic, smokers, unemployed or have
HIV. Once again, through the table 4.1 it is possible to see that around 76% to 93% of the
alcoholic, smokers, unemployed and HIV positive are males. The percentage of drug addicts
is 8%. Among the drugs addicts, 87% are males. Only 5% of the individuals have diabetes.
Among individuals with diabetes 69% are males. A very small percentage of patients (1% to
2%) are in prison, are homeless or live in a community residence. However, the percentage of
missing information for these variables is higher (6%), which can indicate that the real number
is actually different. The percentage of men is always superior to the percentage of woman,
exept for the variable Job. The proportion of males in the category "Yes" of the variables
representing the risk factor is equivalent to proportion of males with missing information.
The median time of follow-up is 1303 days and the mean time is 1383 days. The follow-up
time ranges between 1 day and 3049 days. The distribution of the follow-up time is shown in
figure 4.5.
Individuals with a recurrent episode
Only a small number of patients (145) had a recurrent episode during the time studied. The
proportion of men is much higher (77%) than the proportion of women.
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Variables Female Male Total
Job
Yes 135 (57.4%) 100 (42.6%) 235 (2.8%)
No 2228 (30.4%) 5098 (69.6%) 7326 (87.6%)
Missing 290 (36.1%) 513 (63.9%) 803 (9.6%)
Alc
Yes 94 (7%) 1253 (93%) 1347 (16.1%)
No 2461 (37.9%) 4032 (62.1%) 6493 (77.6%)
Missing 98 (18.7%) 426 (81.3%) 524 (6.3%)
Smk
Yes 120 (13%) 802 (87%) 922 (11%)
No 2442 (34.8%) 4576 (65.2%) 7018 (83.9%)
Missing 91 (21.5%) 333 (78.5%) 424 (5.1%)
Drugs
Yes 88 (13%) 586 (87%) 674 (8.1%)
No 2468 (34.4%) 4710 (65.6%) 7178 (85.8%)
Missing 97 (19%) 415 (81%) 512 (6.1%)
Prison
Yes 7 (13.7%) 44 (86.3%) 51 (0.6%)
No 2557 (32.6%) 5288 (67.4%) 7845 (93.8%)
Missing 89 (19%) 379 (81%) 468 (5.6%)
Commu
Yes 45 (24%) 143 (76%) 188 (2.2%)
No 2511 (32.7%) 5176 (67.3%) 7687 (91.9%)
Missing 97 (19.8%) 392 (80.2%) 489 (5.9%)
Hmless
Yes 11 (12.1%) 80 (87.9%) 91 (1.1%)
No 2555 (32.7%) 5256 (67.3%) 7811 (93.4%)
Missing 87 (18.8%) 375 (81.2%) 462 (5.5%)
Unemp Yes 260 (23.2%) 863 (76.8%) 1123 (13.4%)No 2393 (33%) 4848 (67%) 7241 (86.6%)
HIV Yes 178 (21.3%) 658 (78.7%) 836 (10%)No 2475 (32.9%) 5053 (67.1%) 7528 (90%)
Diabetes Yes 140 (31%) 312 (69%) 452 (5.4%)No 2513 (31.8%) 5399 (68.2%) 7912 (94.6%)
Table 4.1: Distribution of number of cases and missing observations by gender and according
to several risk factors (n = 8364)
Figure 4.5: Distribution of the follow-up time
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Three quarters of the recurrent cases have between 20 and 50 years. Figure 4.6 represents the
distribution of the age of recurrent individuals.
Figure 4.6: Distribution of the age of recurrent cases
The mean age of the patients is 38 years and the median is 34 years. For males the median
age is 37 and for females is 29 years. More than 90% of these were born in Portugal.
More than half (67.6%) of those who had a recurrent episode have at least one of the con-
sidered risk factors (health care job, alcoholism, smoking, drug problem, in prison, living in a
community residence, homeless, unemployed or with HIV or diabetes) (table 4.2).
Among individuals who had a recurrent episode during the time of the study between 15 %
to 30 % are either alcoholics, smokers, unemployed, have HIV or drug addicts. Less than
1% have diabetes. Between 1% to 6% are health care workers, homeless, in a prison or in a
community residence. All the individuals that are in prison, lives in a community residence or
are homeless are males. Between 85% to 98% of the individuals with HIV, smokers, alcoholics,
unemployed or drug addicts are males. The variables (health care workers, alcoholic, smoker,
drugs, prison, community and homeless) have between 5% to 15% of missing information.
The percentage of men is always superior to the percentage of woman, except for the variable
Job. The proportion of males in the category "Yes" of the variables representing the risk factor
is equivalent to proportion of males with missing information.
Most of the recurrent episodes (61%) happened within the first two years after the end of the
first episode. Only around 6% of the episodes happened 5 years or more after the end of the
first episode. Figure 4.7 illustrates the distribution of time to a recurrent episode.
Figure 4.8 shows how long it takes for the recurrent episode to occur depending on the previous
outcome. Almost all the cases that have defaulted have another episode of TB in the following
two years (91%) while only a smaller percentage (49%) of the patients with a previously treated
episode have another episode in the same period of time.
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Variables Female Male Total
Job
Yes 1 (50%) 1 (50%) 2 (1.4%)
No 29 (23.6%) 94 (76.4%) 123 (84.8%)
Missing 4 (20%) 16 (80%) 20 (13.8%)
Alc
Yes 1 (2.4%) 40 (97.6%) 41 (28.3%)
No 31 (34.4%) 59 (65.6%) 90 (62.1%)
Missing 2 (14.3%) 12 (85.7%) 14 (9.6%)
Smk
Yes 3 (7.5%) 37 (92.5%) 40 (27.6%)
No 29 (30.2%) 67 (69.8%) 96 (66.2%)
Missing 2 (22.2%) 7 (77.8%) 9 (6.2%)
Drugs
Yes 1 (4.2%) 23 (95.8%) 24 (16.6%)
No 31 (29.5%) 74 (70.5%) 105 (72.4%)
Missing 2 (12.5%) 14 (87.5) 16 (11%)
Prison
Yes 0 (0%) 4 (100%) 4 (2.7%)
No 33 (25.6%) 96 (74.4%) 129 (89%)
Missing 1 (8.3%) 11 (91.7%) 12 (8.3%)
Commu
Yes 0 (0%) 8 (100%) 8 (5.5%)
No 32 (25.8%) 92 (74.2%) 124 (85.5%)
Missing 2 (15.4%) 11 (84.6%) 13 (9%)
Hmless
Yes 0 (0%) 6 (100%) 6 (4.1%)
No 33 (25.8%) 95 (74.2%) 128 (88.3%)
Missing 1 (9%) 10 (91%) 11 (7.6%)
Unemp Yes 5 (14.3%) 30 (85.7%) 35 (24.1%)No 29 (26.4%) 81 (73.6%) 110 (75.9%)
HIV Yes 5 (12.2%) 36 (87.8%) 41 (28.3%)No 29 (27.9%) 75 (72.1%) 104 (71.7%)
Diabetes Yes 0 (0%) 1 (100%) 1 (0.7%)No 34 (23.6%) 110 76.4% 144 (99.3%)
Table 4.2: Distribution of number of cases and missing observations by gender and according
to several risk factors (n = 145)
Figure 4.7: Distribution of time to a recurrent episode
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Figure 4.8: Boxplot of time (in years) after the end of the first episode until recurrence,
according to the previous outcome
Individuals with censored observations
Most of the patients (8219) did not have a recurrent episode during the time studied.
The majority (66%) of the censored observations correspond to individuals that are between
20 and 50 years old. Less than 1% of the cases are less than 10 years or more than 90 years.
Figure 4.9 represent the distribution of the age for individuals with censored observations.
Figure 4.9: Distribution of the age for individuals with censored observations
The mean age is 43 years and the median is 40 years. For males the median age is 42 and for
females is 35 years. Around 10% of the censored observations corresponds to individuals that
were not born in Portugal.
Half (50%) of the individuals with censored observations have at least one of the considered
risk factor (health care job, alcoholic, smoker, drug problem, in prison or community residence,
homeless, unemployed or has HIV or diabetes) (table 4.3).
Among individuals that did not have an episode during the time of the study, 8% to 16% are
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alcoholics, smokers, unemployed, have HIV or are drug addicts. Less than 5% are health care
workers, have diabetes, are homeless or lives in a prison or in a community residence. As seen in
table 4.3, around 60% of the health workers are women. Among individuals with diabetes, HIV,
unemployed, smokers, alcoholics, drug dependents, homeless, living in a community residence
or in prison, more than 69% are males. The variables (health care workers, alcoholic, smoker,
drugs, prison, community and homeless) have less than 10% of missing information. The
percentage of men is always superior to the percentage of woman, except for the variable Job.
The proportion of males in the category "Yes" of the variables representing the risk factor is
equivalent to proportion of males with missing information.
Variables Female Male Total
Job
Yes 134 (57.5%) 99 (42.5%) 233 (2.8%)
No 2199 (30.5%) 5004 (69.5%) 7203 (87.6%)
Missing 286 (36.5%) 497 (63.5%) 783 (9.6%)
Alc
Yes 93 (7.1%) 1213 (92.9%) 1306 (15.9%)
No 2430 (38%) 3973 (62%) 6403 (77.9%)
Missing 96 (18.8%) 414 (81.2%) 510 (6.2%)
Smk
Yes 117 (13.3%) 765 (86.7%) 882 (10.7%)
No 2413 (34.9%) 4509 (65.1%) 6922 (84.2%)
Missing 89 (21.4%) 326 (78.6%) 415 (5.1%)
Drugs
Yes 87 (13.4%) 563 (86.6%) 650 (7.9%)
No 2437 (34.5%) 4636 (65.5%) 7073 (86.1%)
Missing 95 (19.1%) 401 (80.9) 496 (6%)
Prison
Yes 7 (14.9%) 40 (85.1%) 47 (0.6%)
No 2524 (32.7%) 5192 (67.3%) 7716 (93.9%)
Missing 88 (19.3%) 368 (80.7%) 456 (5.5%)
Commu
Yes 45 (25%) 135 (75%) 180 (2.2%)
No 2479 (32.8%) 5084 (67.2%) 7563 (92%)
Missing 95 (20%) 381 (80%) 476 (5.8%)
Hmless
Yes 11 (13%) 74 (87%) 85 (1%)
No 2522 (32.8%) 5161 (67.2%) 7683 (93.5%)
Missing 86 (19.1%) 365 (80.9%) 451 (5.5%)
Unemp Yes 255 (23.4%) 833 (76.6%) 1088 (13.2%)No 2364 (33.1%) 4767 (66.9%) 7131 (86.8%)
HIV Yes 173 (21.8%) 622 (78.2%) 795 (9.7%)No 2446 (32.9%) 4978 (67.1%) 7424 (90.3%)
Diabetes Yes 140 (31%) 311 (69%) 451 (5.5%)No 2479 (31.9%) 5289 (68.1%) 7768 (94.5%)
Table 4.3: Distribution of number of cases and missing observations by gender and according
to several risk factors (n = 8219)
Almost three quarters of the individuals have censored observations 1 year to 5 years after the
end of the first episode. Figure 4.10 illustrates the distribution of follow-up time for individuals
with censored observations.
Table 4.4 provides a summary of all the variables considered for patients that had a recurrent
episode and for those who did not had.
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Figure 4.10: Distribution of follow-up time for individuals with censored observations
Table 4.4: Summary of the final dataset
Variable Category Recurrent No-recurrent Total
Vac
No 32 1317 1349
Yes 26 2050 2076
NA 87 4852 4939
CliForm
Pulmonary 122 7533 7655
Extra pulmonary 23 684 707
NA 0 2 2
Radio
Normal 10 534 544
Without Cavitation 60 3198 3258
With cavitation 59 3950 4009
NA 16 537 553
Sit Cured 102 7994 8096Default 43 225 268
HIV No 104 7424 7528Yes 41 795 836
Diabetes No 144 7768 7912Yes 1 451 452
NumCo
0 93 6214 6307
1 47 1736 1783
+2 5 269 274
Sex Female 34 2619 2653Male 111 5600 5711
age Mean (IQR) 38.26 (29-44) 43.05 (30-53) 42.97 (30-53)Standard Deviation 14.31 17.06 17.02
Origin
Portuguese 131 7313 7444
Low-risk 1 49 50
High-risk 13 841 854
NA 0 16 16
Continue on next page
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Table 4.4 – continued from previous page
Variable Category Recurrent No-recurrent Total
Smk
No 96 6922 7018
Yes 40 882 922
NA 9 415 424
Alc
No 90 6403 6493
Yes 41 1306 1347
NA 14 510 524
Unemp No 110 7131 7241Yes 35 1088 1123
Drugs
No 105 7073 7178
Yes 24 650 674
NA 16 496 512
Prison
No 129 7716 7845
Yes 4 47 51
NA 12 456 468
Job
No 123 7203 7326
Yes 2 233 235
NA 20 783 803
Commu
No 124 7563 7687
Yes 8 180 188
NA 13 476 489
Hmless
No 128 7683 7811
Yes 6 85 91
NA 11 451 462
Transf No 140 7979 8119Yes 5 240 245
4.2 Exploratory Analysis of Missing Data
Although most studies ignore missing data and perform only a complete case analysis (even
when this is not the most appropriate solution), some studies do not ignore this issue and
explore and impute the missing values (48; 89; 90).
As previously shown, the predictor variables have a large amount of missing values. Figure
4.11 shows the frequency of missing data per individual. Only 34% (2890) of the patients had
complete data, whereas 66% (5474) of the patients had one or more missing predictors. Most
frequently (46%) there was one predictor with missing data per patient.
Despite the large proportion of missing data, this proportion seems to be decreasing over time,
as observed in figure 4.12.
This decrease seems to indicate a growing concern with the epidemiology of TB by clinical
practitioners. In fact, most of the variables showing this decrease, such as being alcoholic,
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Figure 4.11: Number of missing variables per subject
smoker, drug-addicted or in prison, are known risk factors for the recurrence of TB (29; 30).
Pulmonary cavities observed in radiological exams have been associated with recurrence of TB
(29; 30), thus, the observed decrease in missing data over time on this variable may be also an
indication of an increased concern in understanding the disease. Interestingly, missing data for
the variable symptoms does not seem to decrease over time, remaining almost constant. This
is not unexpected since this variable depends on retrospective self-diagnosis from the patients,
which is not expected to improve over the years.
As discussed in section 3.1, the missingness pattern can be classified as monotone or nonmono-
tone. The purpose of figure 4.13 is to shed light on the pattern of missingness in this dataset.
A monotonic pattern can also be identified by the no return, i.e., once a subject dropped out
he will drop out forever, not returning to the study. Whereas, in a non-monotonic pattern the
subject may come back or be missing again.
In order to assess the type of missing data of the dataset, a test proposed by Little et al (91)
to explore the validity of the MCAR hypothesis was used. The null hypothesis states that the
data are MCAR. To implement this test, the function LittleMCAR, in R, was used (92). The
test results indicate that there are significant differences between the missing values and the
observed values, so there is evidence that the data is not MCAR (chi-sq = 11031.29, df=
3777, p-value = 0).
Another interesting analysis is to compare the survival curves of groups of individuals with and
without missing information for each predictor separately (figure 4.14).
Through the analysis of figure 4.14, the Kaplan-Meier estimates for the variables radiology
and symptoms do not appear to show visual differences. However, some visual differences are
observed in the plots for the variables vaccine, alcohol, drugs, smoke, prison and homeless.
The log-rank and Peto-Peto tests were used to evaluate the existence of significant differences
between the curves. There was a significant difference between the survival distributions of
patients with and without missing information for vaccine, alcohol, drugs and the remaining
variables. The patients with missing values in vaccine (p-value = 0.06), prison (p-value <
0.001), community residence (p-value < 0.001), smoke (p-value < 0.001) and homeless (p-
value < 0.001) had a better prognosis, which could lead to an underestimation of the true
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Figure 4.12: Proportion of missing (light gray) and observed data (dark gray) for several
predictors
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Figure 4.13: Amount of missing data in each variable
survival, if those patients were eliminated from the analysis. The opposite was observed for
the variables alcohol (p-value < 0.001) and drugs (p-value < 0.001), with worse prognosis for
patients with missing values. However, some caution should be taken when interpreting these
effects, since this approach is univariate and, therefore, not adjusted for the other variables.
Unfortunately, there is no standard statistical test to determine if data are MAR. In fact, it
is not possible to distinguish between MAR and MNAR using observed data (54). To gain
knowledge into the issue of whether data can be considered MAR, a logistic regression model
is used for the outcome of missingness (90; 93) (Table 4.5). However, many variables had a
problem of complete separation, also known as monotone likelihood. It is observed usually in
small samples with highly predictive risk factors. The phenomenon of separation occurs if the
observed and missing values can be separated by a single risk factor or by a combination of
risk factors. The problem with this situation is the non-existence of the maximum likelihood
estimate (94). To address this problem, the package logistf (95) that implements Firth’s
penalized likelihood logistic regression was used. This analysis indicates that HIV, age, number
of previous treatment and country of origin are associated with the existence of missing values
in several other variables. These results suggest that the missing data could be MAR and the
analysis will be done under this assumption.
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Figure 4.14: Kaplan-Meier estimates of the survivor function for several groups
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4.3 Non-parametric Inference
For categorical variables time until the second episode of TB was analyzed using the Kaplan-
Meier estimator and the log-rank and Peto-Peto tests. The univariate analysis was performed
on the complete cases in the original dataset (n=2890).
The Kaplan-Meier estimator was used to estimate the survivor function of the time from the
end of the first episode of TB until the beginning of the second episode of TB for all individuals
in the dataset.
Figure 4.15: Kaplan-Meier estimate of the survivor function of time until the begining of the
second episode of TB
Figure 4.15 shows that the survival curve slowly decreases along the years. Seven years after
the end of the first treatment, it is estimated that less than 5% will have developed a second
episode of disease. Therefore it is not possible to estimate the median or the most used
quantiles. Table 4.6 presents a brief summary.
Years Number at risk Number of events Probability of non-recurrence
1 2890 17 0.994
2 2843 11 0.990
3 2250 4 0.989
4 1753 5 0.986
5 1243 4 0.983
6 910 4 0.978
7 598 1 0.977
Table 4.6: Distribution of the number of events since the end of the first treatment
Next, the Kaplan-Meier estimate of the survivor function was obtained for each variable.
A visual analysis of figure 4.16 suggests that individuals without a BCG vaccine have a slightly
higher probability to have another episode of TB than a vaccinated individual. It is estimated
that individuals that had defaulted the previous episode have a higher probability to have
another episode, compared with those who had a successfull treatment. Individuals with
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Figure 4.16: Kaplan-Meier estimate of the survivor function for each category of several risk
factors, considering complete cases
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an alcoholic dependency, smokers, in prison or unemployed also have a higher risk to have
another episode than someone who does not drink, smokes, is not in prison nor unemployed,
respectively. The analysis was repeated for the remaining variables, although the plots are not
presented here. Individuals with an extrapulmonary form of TB have a higher risk to have
another episode than individuals with pulmonary form of TB. Individuals born in Portugal
have a smaller risk of recurrence than foreigners. No visual difference was found between the
survival curves for gender and different types of radiology. Individuals with a drug dependence,
living in a community residence, homeless or with HIV are more risk to have another episode
of TB. Whereas, individuals that were transfered to another hospital, that have Diabetes and
have two more diseases have less risk to have another episode episode of TB.
To analyze how meaningfull were the differences suggested by the graphics the log-rank test
and Peto-Peto test were used (table 4.7).
Variables Test log-rank Test Peto-Peto
χ2(df) p-value χ2(df) p-value
Vac 4 (1) 0.04 4 (1) 0.04 **
CliForm 3.7 (1) 0.05 3.7 (1) 0.05 **
Radio 2.7 (2) 0.26 2.7 (2) 0.26
Sit 141 (1) 0.00 142 (1) 0.00 ***
Sex 1.5 (1) 0.22 1.5 (1) 0.22
Origin 1.8 (2) 0.41 1.8 (2) 0.41
Job 0.1 (1) 0.70 0.1 (1) 0.71
Alc 6.3 (1) 0.01 6.3 (1) 0.01 ***
Smk 19.4 (1) 0.00 19.5 (1) 0.00 ***
Drugs 9.9 (1) 0.00 9.9 (1) 0.00 ***
Prison 21.7 (1) 0.00 21.9 (1) 0.00 ***
Commu 5.5 (1) 0.02 5.5 (1) 0.02 **
Hmless 0.9 (1) 0.34 0.9 (1) 0.33
Transf 1.1 (1) 0.29 1.1 (1) 0.29
Unemp 4.5 (1) 0.03 4.5 (1) 0.03 **
HIV 33.3 (1) 0.00 33.4 (1) 0.00 ***
Diabetes 2.1 (1) 0.15 2.1 (1) 0.15
NumCo 6.4 (2) 0.04 6.4 (2) 0.04 **
Table 4.7: Log-rank test and Peto-Peto test results for each variable. Signif. codes: < 0.01
’***’ 0.05 ’**’ 0.1 ’*’
The survival curves for radiology, gender, country of birth, job, homeless, transfered and
diabetes did not displayed significant differences, while for all the remaining variables, the
survival curves displayed significant differences. These results are somewhat in accordance
with the visual inspection of the survival curves.
4.4 Complete Case Analysis
In presence of missing data, one of the most common strategy is to consider only the individuals
without missing observations. However, as previously discussed in section 3.1.1 using this
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method if the data is not MCAR will lead to biased results. Here, a Cox model was fitted to
the complete case data.
4.4.1 Cox Regression Analysis
After removing the missing values, the dataset for analysis has 2890 observations.
To find which variables were significant using the Cox model, a strategy for selecting variables
proposed by Collett (77) was used. The first step consists in performing an univariate analysis,
in order to assess the individual influence of each variable. The results obtained are in table
4.8.
Variable -2 log Lˆ p-value
Null model 698.35 -
Vac 694.41 0.05 **
CliForm 695.47 0.09 *
Radio 695.67 0.26
Sit 652.98 0.00 ***
Sex 696.80 0.21
Origin 697.00 0.51
Job 698.19 0.69
Alc 693.22 0.02 **
Smk 685.37 0.00 ***
Drugs 691.51 0.01 ***
Prison 691.78 0.01 ***
Commu 695.01 0.07 *
Hmless 697.70 0.42
Transf 696.12 0.14
Unemp 694.54 0.05 **
HIV 679.88 0.00 ***
Diabetes 694.26 0.04 **
NumCo 693.05 0.07 *
age 694.56 0.05 **
Table 4.8: Values of -2 log Lˆ and p-values of Likelihood ratio tests obtained in the univariate
analysis (CC). Signif. codes: < 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
When using this selection procedure, it is recommended to consider a significance level around
10%. For this reason, the variable CliForm is kept in the model for further analysis. If a strict
significance level of 5% was used, CliForm, Commu and NumCo would be eliminated from the
analysis. The variables Job, Origin, Hmless, Radio, Sex and Transf were discarded.
The variable Diabetes was also excluded although the significance level is below 10 %. The
reason to remove this variable is mainly due to a separation problem, commonly named mono-
tone likelihood when fitting a Cox model. The phenomenon of monotone likelihood is not
unsual in highly censored samples with strong predictive covariates (96). Monotone likelihood
causes parameter estimates to diverge, therefore classical maximum likelihood fails and the
confidence intervals cover the whole range of real numbers. The problem is the unability to
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obtain the maximum of the likelihood function and it is easily spotted by the value of the
Hazard ratio and an insignificant Wald test; in this case, the variable Diabetes is the smallest
of all covariate values (βˆ = -15.82, exp(βˆ) = 0.00000013, se(βˆ) = 2797, p-value = 0.9955,
CI (95%) = [0.00; ∞]). To address this issue, the package coxph (97) was used since it
implements the Firth’s penalized maximum likelihood bias reduction for the Cox regression.
Although Firth’s penalized likelihood method is superior to maximum likelihood analysis, it
was still not possible to properly estimate the parameters for the variable Diabetes and for this
reason, Diabetes was removed from this analysis.
A Cox model including all the remaining variables was then fitted to the data. Results are
presented in table 4.9.
-2 log Lˆ p-value
Model with all 619.19 -
Model without Vac 622.39 0.07 *
Model without CliForm 623.54 0.04 **
Model without Sit 654.79 0.00 ***
Model without Alc 621.25 0.15
Model without Smk 620.12 0.33
Model without Drugs 620.21 0.31
Model without Prison 622.72 0.06 *
Model without Commu 620.87 0.19
Model without Unemp 619.41 0.64
Model without HIV 624.40 0.02 **
Model without NumCo 620.21 0.60
Model without age 623.26 0.03 **
Table 4.9: Values of -2 log Lˆ and p-values of Likelihood ratio tests (CC). Signif. codes: <
0.01 ’***’ 0.05 ’**’ 0.1 ’*’
The variables that, when omitted did not significantly increased the value of -2 log Lˆ, were
discarded from the model one by one. This process was repeated every time a variable was
removed from the model. The variables that remained in the model were Vac, CliForm, Sit,
Prison, HIV and age.
In the third step, the variables that were discarded and not considered in the second step are
introduced one by one in the model. If the inclusion of any of the variables reduces significantly
the value of -2 log Lˆ, the variable is retained in the model. No variable had a significant result.
Therefore, the variables Vac, Sit, Prison, HIV, age and CliForm were included in the final Cox
model. The results obtained fitting this model to the data can be seen in table 4.10.
The hazard ratio, exp(βˆ), was estimated for the variables (table 4.10). Values above 1 indicate
higher risk while, value between 0 and 1 point out to a protection effect. Adjusting for the
remaining variables, it is estimated that:
◦ An individual that was not vaccinated has an increase of 80% in the risk of a recurrent
episode when compared with a vaccinated individual;
◦ The risk of recurrence in individuals with an extrapulmonary form of TB is 2.59 times
that of individuals with a pulmonary form of TB;
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βˆ exp(βˆ) se(βˆ) Z p-value CI (95 %)
Vac1 0.59 1.81 0.32 1.84 0.07 [0.96;3.41]
CliForm1 0.95 2.59 0.45 2.12 0.03 [1.07;6.26]
Sit1 2.56 12.98 0.35 7.41 0.00 [6.59;25.56]
Prison1 2.33 10.25 0.74 3.16 0.00 [2.42;43.36]
HIV1 1.19 3.29 0.36 3.31 0.00 [1.62;6.67]
age -0.03 0.97 0.01 -2.08 0.04 [0.95;1.00]
Table 4.10: Results using the Cox model (CC)
◦ The risk of recurrence in individuals that defaulted the previous treatment is 12.98 times
that of individuals who completed the treatment;
◦ The risk of recurrence for an inmate or someone insered in a prison environment is 10.25
times that of someone who is not at the prison;
◦ The risk of recurrence for someone with HIV is 3.29 times that of someone without HIV;
◦ Each additional year of age is associated with an estimated 3% decrease in risk. An
additional decade corresponds to 2% decrease, exp(10 ∗ −0.03).
The confidence interval for age is quite narrow, capturing only a small range of effect sizes.
However, the confidence intervals of Sit, Prison and HIV are wider, capturing a large range of
effect sizes. Therefore, the estimates are more imprecise.
4.4.2 Residual Analysis
Schoenfeld Residuals
An important issue when fitting a Cox model is the validity of the proportional risks assumption.
Schoenfeld residuals were used to evaluate the proportionality of risks for each covariate. The
goal is to assess if the effect of each covariate changes with time.
Besides the visual analysis (figure 4.17), it is possible to test the existence of linear correlation
between the residuals and time.
rho χ2 p-value
Vac1 0.119 0.687 0.407
CliForm1 -0.024 0.027 0.869
Sit1 -0.215 2.430 0.119
Prison1 -0.022 0.022 0.883
HIV1 0.0423 0.1010 0.751
age 0.163 0.688 0.407
GLOBAL NA 4.277 0.639
Table 4.11: Test for proportionality of risks (CC)
The results in table 4.11 show the proportionality of the hazard functions, so there is no
evidence of non proportional hazards. However, the decision should be based both on the
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Figure 4.17: Plot of the Schoenfeld residuals (CC)
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results of the test and the analysis of the graphics in figure 4.17. A line paralel to the X-axis
supports the assumption of proportionality of risks. The smooth line of the variables HIV,
Vacine, CliForm and Sit have a oscillatory behaviour, but without a clear trend. Therefore,
this is not an indication to reject the hypothesis of proportionality.
Martingale Residuals
The martingale residuals were used in order to find if there are any individuals who were poorly
fitted by the model, as well as to investigate the functional form of the continuous variables
(figure 4.18).
Figure 4.18: Plot of the martingale residuals (CC)
The plot of the martingale residuals versus the index of each individual in figure 4.18, does
not present any pattern, corresponding to a good fit since the residuals are evenly distributed
above and under zero. Regarding the functional form of the variable age, in figure 4.18, the
behaviour of the residuals are linear.
4.4.3 Collinearity
Evaluating the existence of collinearity between the covariates is essential since its existence
difficults the estimation of the coefficients. Values of Variance Inflation Factor (VIF) above
10 are considered problematic (87). When the VIF is approximately 1 the covariates are
independent (table 4.12).
Vac CliForm Sit Prison HIV age
1.180 1.042 1.102 1.021 1.066 1.129
Table 4.12: Values of VIF (CC)
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4.5 Complete Case Analysis Without Vaccine
Another approach commonly used in the presence of a variable with a huge amount of missing
data, like the variable Vaccine, is to ignore the variable and perform a complete case analysis
on the remaining variables. Since the variable Vaccine was removed from this analysis, the
complete dataset has 6413 observations.
4.5.1 Cox Regression Analysis
The variables were selecting following the method proposed by Collett (77). The results of the
univariate analysis are in table 4.13.
Variable -2 log Lˆ p-value
Null model 1661.823 -
CliForm 1656.20 0.02 **
Radio 1661.29 0.77
Sit 1564.31 0.00 ***
Sex 1657.79 0.04 **
Origin 1661.47 0.84
Job 1661.35 0.49
Alc 1652.05 0.00 ***
Smk 1644.12 0.00 ***
Drugs 1653.71 0.00 ***
Prison 1655.01 0.01 ***
Commu 1653.89 0.00 ***
Hmless 1658.66 0.08 *
Transf 1661.82 1.00
Unemp 1657.34 0.03 **
HIV 1644.43 0.00 ***
Diabetes 1656.59 0.02 **
NumCo 1657.37 0.11
age 1656.04 0.02 **
Table 4.13: Values of -2 log Lˆ and p-values of Likelihood ratio tests obtained in the univariate
analysis (CC without Vaccine). Signif. codes: < 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
The variables Radio, Origin, Job, Transf and NumCo were eliminated from the analysis since
they are not significant at a 10% level.
A Cox model including all the remaining variables was fitted to the data. Results are presented
in table 4.14.
The variables that, when omitted did not significantly increased the value of -2 log Lˆ, were
discarded from the model one by one. This process was repeated every time a variable was
removed from the model. Afterwards, the variables discarded in the univariate analysis were
introduced one by one in the model. Since none of them significantly reduced the value of -2
log Lˆ they were not included in the final model. The results obtained fitting this model to the
data can be seen in table 4.15.
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-2 log Lˆ p-value
Model with all 619.19 -
Model without CliForm 1532.832 0.043 **
Model without Sit 1609.590 0.000 ***
Model without Sex 1529.945 0.2687
Model without Alc 1532.519 0.051 *
Model without Smk 1529.980 0.262
Model without Drugs 1530.288 0.211
Model without Prison 1533.494 0.029 **
Model without Commu 1532.869 0.0417 **
Model without Hmless 1528.726 0.950
Model without Unemp 1528.786 0.800
Model without HIV 1530.250 0.216
Model without Diabetes 1531.846 0.077 *
Model without age 1532.523 0.051 **
Table 4.14: Values of -2 log Lˆ and p-value of Likelihood ratio tests (CC without Vaccine).
Signif. codes: < 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
βˆ exp(βˆ) se(βˆ) Z p-value CI (95 %)
CliForm1 0.803 2.233 0.302 2.659 0.008 [0.211;1.395]
Sit1 2.640 14.012 0.226 11.681 0.000 [2.197;3.083]
Alc1 0.532 1.702 0.233 2.283 0.022 [0.075;0.988]
Prison1 1.714 5.550 0.599 2.861 0.004 [0.541;2.887]
Commu1 1.076 2.933 0.395 2.724 0.006 [0.302;1.850]
Diabetes1 -1.425 0.241 1.009 -1.412 0.158 [-3.403;0.554]
age -0.013 0.987 0.007 -1.857 0.063 [-0.027;0.000]
Table 4.15: Results using the Cox model (CC without Vaccine)
63
Chapter 4. Evaluation of risk factors for time to recurrence
The variable Diabetes is no longer significant at a 10% level. The hazard ratio, exp(βˆ), was
estimated for the variables (table 4.15). Adjusting for the remaining variables, it is estimated
that:
◦ The risk of recurrence in individuals with an extrapulmonary form of TB is 2.23 times
that of individuals with a pulmonary form of TB;
◦ The risk of recurrence in individuals who defaulted the previous episode is 14 times that
of individuals who completed the treatment;
◦ An alcoholic individual has an increase of 70% in the risk of a recurrent episode when
compared with someone who does not drink;
◦ The risk of recurrence for an individual incarcerated is 5.55 times that of someone who
is not incarcerated;
◦ The risk of recurrence for someone living in a community residence is 2.93 times that of
someone that does not live in a residence community;
◦ Each additional year of age is associated with an estimated 1 % decrease in risk. An
additional decade corresponds to 12% decrease.
It is important to highlight that all confidence intervals are quite large, indicating more uncer-
tainty about the true estimate of the coefficient. It is also important to note that the variable
HIV was not considered significant in this model, which is unexpected due to the vast literature
about its significance.
4.5.2 Residual Analysis
Schoenfeld Residuals
An important analysis is to evaluate the validity of the proportional risk assumption, i.e., to
observe if the effect of a covariate changes with time. A visual analysis was performed (figure
4.19) and a test to determine the correlation between the residuals and the time (table 4.16).
rho χ2 p-value
CliForm1 0.147 2.098 0.147
Sit1 -0.465 22.681 1.9e-06
Alc1 0.145 2.227 0.136
Prison1 -0.096 0.991 0.319
Commu1 -0.054 0.294 0.588
Diabetes1 -0.1309 1.674 0.196
age -0.188 3.323 0.068
GLOBAL NA 28.811 1.6e-04
Table 4.16: Test for proportionality of risks (CC without Vaccine)
As seen in table 4.15, the variable Sit have a strong effect on the risk for recurrence. The test
suggests that this effect is significantly non proportional. However, if one observes the plot
in figure 4.19, the variation in βˆ(t) is not far from the estimate of βˆ. It is also important to
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Figure 4.19: Plot of the Schoenfeld residuals (CC without Vaccine)
65
Chapter 4. Evaluation of risk factors for time to recurrence
notice that the sample size has increased due to the exclusion of the variable vaccine. It is
known that with very large samples p-values quickly reach 0, therefore, relying exclusively on
p-values is not appropriate. In fact, some outliers may cause the hypothesis of proportionality
to be rejected. Figure 4.20 shows that the significant test for nonproportionality is mainly due
to the existence of very early event times that appears as outliers in the log scale.
Figure 4.20: Outliers and test for proportionality of risks (CC without Vaccine)
Another possible cause for the nonproportionality is the omission of important covariates, as
explained in section 2.2.1. In this case, the Schoenfeld residuals plots may suggest the presence
of nonproportionality.
Martingale Residuals
The martingale residuals were used in order to find if there are any individuals who were poorly
fitted by the model, as well as to investigate the functional form of continuous variables (figure
4.21).
Figure 4.21: Plot of the martingale residuals (CC without Vaccine)
The plot of the martingale residuals versus the index of each individual, in figure 4.21, does
not present any pattern, corresponding to a good fit since the residuals are evenly distributed
above and under zero. Regarding the functional form of the variable age, in figure 4.21, the
behaviour of the residuals are linear.
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4.5.3 Collinearity
Evaluating the existence of collinearity between the covariates is essential since its existence
difficults the estimation of the coefficients. Values of VIF above 10 are considered problematic
(87). When the VIF is approximately 1 the covariates are independent (table 4.17).
CliForm Sit Alc Prison Commu Diabetes age
1.026 1.040 1.084 1.037 1.013 1.008 1.035
Table 4.17: Values of VIF (CC without Vaccine)
4.6 Mean Imputation
Another commonly used method is single mean imputation, although it is not recommend
for categorical variables. For numeric variables, this method replace the missing values by
the column median while as for categorical variables missing values are replaced by the most
frequent value (ties are randomnly atributed).
4.6.1 Cox Regression Analysis
To find significant variables in the dataset obtained with mean imputation the same method
of variable selection was used. The results of the univariate analysis are in table 4.18.
The variables Radio, Origin, Job and Transf were discarded. A Cox model with all the remaining
variables was fitted to the data. Results are presented in table 4.19.
As before, the variables that, when omitted did not significantly increased the value of -2 log Lˆ,
were discarded from the model one by one. At the end, the significant variables were Sit, Alc,
age, Prison, HIV, CliForm, Diabetes and Vac.
The variables Job, Radio, Transf and Origin did not reduced significantly the value of -2 log Lˆ.
The results of the final model can be seen in table 4.20.
The hazard ratio, exp(βˆ) , was estimated for the variables (table 4.20). Adjusting for the
remaining variables, it is estimated that:
◦ An individual that was not vaccinated has an increase of 70% in the risk of a recurrent
episode when compared with a vaccinated individual;
◦ An individual with an extrapulmonary form of TB has an increase of 95% in the risk of
a recurrent episode when compared with an individual with a pulmonary form of TB;
◦ The risk of recurrence in individuals that defaulted the treatment is 9.99 times that of
individuals who completed the treatment;
◦ An alcoholic individual has an increase of 80% in the risk of a recurrent episode when
compared with a non alcoholic individual;
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Variable -2 log Lˆ p-value
Null model 2543.59 -
Vac 2539.89 0.05 **
CliForm 2533.18 0.00 ***
Radio 2543.07 0.77
Sit 2409.90 0.00 ***
Sex 2538.79 0.03 **
Origin 2543.35 0.89
Job 2542.30 0.26
Alc 2529.71 0.00 ***
Smk 2510.96 0.00 ***
Drugs 2530.71 0.00 ***
Prison 2537.23 0.01 ***
Commu 2538.02 0.02 **
Hmless 2535.84 0.01 **
Transf 2543.53 0.82
Unemp 2529.85 0.00 ***
HIV 2502.97 0.00 ***
Diabetes 2533.65 0.00 ***
NumCo 2531.87 0.00 ***
age 2533.47 0.00 ***
Table 4.18: Values of -2 log Lˆ and p-value of Likelihood ratio tests obtained in the univariate
analysis (Mean imputation). Signif. codes: < 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
-2 log Lˆ p-value
Model with all 2346.04 -
Model without Vac 2352.36 0.01 ***
Model without CliForm 2353.95 0.005 ***
Model without Sit 2444.351 0.00 ***
Model without Sex 2346.38 0.56
Model without Alc 2353.97 0.005 ***
Model without Smk 2347.99 0.16
Model without Drugs 2348.18 0.14
Model without Prison 2350.63 0.03 **
Model without Commu 2346.68 0.42
Model without Hmless 2347.04 0.32
Model without Unemp 2346.28 0.62
Model without HIV 2351.26 0.02 **
Model without Diabetes 2349.11 0.08 *
Model without NumCo 2348.18 0.34
Model without age 2351.40 0.02 **
Table 4.19: Values of -2 log Lˆ and p-values of Likelihood ratio tests (Mean imputation). Signif.
codes: < 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
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βˆ exp(βˆ) se(βˆ) Z p-value CI (95 %)
Vac1 0.544 1.723 0.204 2.667 0.008 [0.144;0.944]
CliForm1 0.668 1.950 0.235 2.843 0.004 [0.208;1.128]
Sit1 2.302 9.998 0.192 11.990 0.000 [1.925;2.680]
Alc1 0.589 1.801 0.191 3.084 0.002 [0.215;0.962]
Prison1 1.433 4.190 0.518 2.766 0.006 [0.417;2.449]
HIV1 0.752 2.121 0.197 3.817 0.000 [0.365;1.138]
Diabetes1 -1.660 0.190 1.007 -1.648 0.099 [-3.635;0.314]
age -0.014 0.986 0.006 -2.333 0.020 [-0.026;-0.002]
Table 4.20: Results using the Cox model (Mean imputation)
◦ The risk of recurrence in individuals in prison is 4.19 times that of individuals that are
not in prison;
◦ The risk of recurrence in individuals with HIV is 2.12 times that of individuals without
HIV;
◦ An individual with Diabetes has a decrease of 80% in the risk of a recurrent episode
when compared with someone without Diabetes;
◦ Each additional year of age is associated with an estimated 1 % decrease in risk. An
additional decade corresponds to a 13% decrease in risk.
The confidence intervals are not large, however, it was previously discussed that mean impu-
tation leads to overestimation of precision.
4.6.2 Residual Analysis
Schoenfeld Residuals
To assess the proportionality of the hazards the Schoenfeld residuals were calculated.
Table 4.21 shows the p-value of the test of proportional hazards for all the variables. As
expected, since the sample size increased, the p-values are low. Therefore, it is expected that
for the variable Sit there is a clear rejection of the null hypothesis of proportionality of risks.
Although the test shows that the residuals of some variables (Sit, Vac and age) are significantly
nonproportional, the residual plot (figure 4.22) shows that the variation in βˆ(t) is small relative
to βˆ, suggesting a non rejection of the hypothesis of proportionality of risks. As before, figure
4.23 shows that the rejection of the proportionality is mainly due to the presence of outliers
observed in the log scale.
Martingale Residuals
To find if there are any individuals who were not well fitted by the model the martingale
residuals were used. These residuals also help to investigate the functional form of continuous
variables, i.e., if the variables are linear or need any transformation.
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Figure 4.22: Plot of the Schoenfeld residuals (Mean imputation)
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rho χ2 p-value
Vac1 0.178 4.661 0.031
CliForm1 0.170 4.386 0.036
Sit1 -0.459 37.867 7.6e-10
Alc1 0.013 0.024 0.876
Prison1 -0.100 1.532 0.216
HIV1 0.130 2.812 0.093
Diabetes1 -0.123 2.196 0.138
age -0.159 3.877 0.049
GLOBAL NA 49.123 6.0e-08
Table 4.21: Test for proportionality of risks (Mean imputation)
Figure 4.23: Outliers and test for proportionality of risks (Mean imputation)
Figure 4.24: Plot of the martingale residuals (Mean imputation)
71
Chapter 4. Evaluation of risk factors for time to recurrence
The plot of the martingale residuals versus the index of each individual, in figure 4.24, does
not present any pattern, corresponding to a good fit since the residuals are evenly distributed
above and under zero. Regarding the functional form of the variable age, figure 4.24, the
behaviour of the residuals are linear.
4.6.3 Collinearity
Evaluating the existence of collinearity between the covariates is essential since its existence
difficults the estimation of the coefficients. Values of VIF above 10 are considered problematic
(87). When the VIF is approximately 1 the covariates are independent (table 4.22).
Vac CliForm Sit Alc Prison HIV Diabetes age
1.038 1.066 1.120 1.068 1.044 1.142 1.008 1.061
Table 4.22: Values of VIF (Mean imputation)
4.7 Predictive Mean Matching
4.7.1 Imputation Diagnosis
After the imputation, with PMM, it is necessary to check if the imputed data are plausible.
In general, a good imputed value is a value that could have been observed had it not been
missing. Differences in the density plots for the observed and imputed values may suggest
the existence of a problem that needs to be further checked. Figure 4.25 represents a density
plot, for each imputed dataset, of the observed and imputed values for the variable Vacine.
All the other variables had similar distributions of imputed and observed values, so there is no
indication of any problem during the imputation process.
Another important diagnosis consists in determining if the Gibbs sampling algorithm has con-
verged. Figure 4.26 represent the variables Commu, Hmless and age plotted against the
number of iterations. To achieve a good convergence, streams should be freely intermingled
with each other, without defining trends. In this case, there is very little trend and the streams
mingle well from the start.
4.7.2 Cox Regression Analysis
As mentioned before, the selection of variables should be done in each imputed dataset and
not only on the pooled data. Therefore, the selection of variables was performed in each of the
imputed dataset. A variable was considered if it was significant in at least half of the models.
The results presented in table 4.23 are an average of the imputed analyses.
The variables Vac, Radio, Transf, Origin and Job were discarded from the analyses. The next
step consist in including all the significant variables in a model and remove one by one to see
its effect. Results are presented in table 4.24.
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Figure 4.25: Kernel density estimates for the marginal distributions of the observed and imputed
values of the Vaccine (PMM)
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Figure 4.26: Convergence of the Gibbs sampler (PMM)
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Variable -2 log Lˆ p-value
Null model 2543.587 -
Vac 2543.099 0.5885
CliForm 2533.189 0.0004 ***
Radio 2539.76 0.1558
Sit 2409.896 0 ***
Sex 2538.786 0.0344 **
Origin 2543.347 0.8977
Job 2542.36 0.3847
Alc 2527.667 6.1e-05 ***
Smk 2507.486 1.8e-10 ***
Drugs 2522.983 6.5e-06 ***
Prison 2537.522 0.0072 ***
Commu 2536.977 0.0080 ***
Hmless 2536.233 0.0022 ***
Transf 2543.535 0.8066
Unemp 2529.851 6.8e-05 ***
HIV 2502.973 9.7e-13 ***
Diabetes 2533.647 0.0354 **
NumCo 2531.870 0.0018 ***
age 2533.430 0.0021 ***
Table 4.23: Values of -2 log Lˆ and p-values of Likelihood ratio tests obtained in the univariate
analysis (PMM). Signif. codes: < 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
-2 log Lˆ p-value
Model with all 2356.92 -
Model without CliForm 2363.754 0.0094 ***
Model without Sit 2452.399 0 ***
Model without Sex 2357.363 0.5115
Model without Alc 2363.0115 0.0201 **
Model without Smk 2358.418 0.2616
Model without Drugs 2358.504 0.2976
Model without Prison 2359.493 0.1958
Model without Commu 2357.481 0.5599
Model without Hmless 2357.376 0.6084
Model without Unemp 2357.450 0.4770
Model without HIV 2361.735 0.0293 **
Model without Diabetes 2359.953 0.0818 *
Model without NumCo 2358.951 0.0293 **
Model without age 2360.915 0.0462 **
Table 4.24: Values of -2 log Lˆ and p-values of Likelihood ratio tests (PMM). Signif. codes:
< 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
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One by one the variable with the lowest increase of -2 log Lˆ was removed from the model.
Sex, Hmless, Unemp, Commu, Drugs, Smk, NumCo and Prison were discarded due to the
low value of -2 log Lˆ. The next step consists of adding each of the discarded variables in the
univariate analysis to the complete model. None of the discarded variable had a significant
increase of -2 log Lˆ, therefore, the final model consists of CliForm, Sit, Alc, HIV, Diabetes and
age. The results presented in table 4.25 are a combination of the multiple analyses through
Rubin’s rules.
βˆ exp(βˆ) se(βˆ) Z p-value CI (95 %)
CliForm=1 0.634 1.885 0.235 2.693 0.0071 [0.172;1.095]
Sit=1 2.280 9.777 0.193 11.808 0 [1.901;2.658]
Alc=1 0.574 1.775 0.195 2.947 0.0032 [0.192;0.956]
HIV=1 0.706 2.026 0.198 3.565 0.0004 [0.318;1.094]
Diabetes=1 -1.68 0.186 1.007 -1.668 0.0952 [-3.654;0.294]
age -0.013 0.987 0.006 -2.142 0.0322 [-0.025;-0.001]
Table 4.25: Results using the Cox model (PMM)
The hazard ratio, exp(βˆ), was estimated for the variables (table 4.25). Adjusting for the
remaining variables, it is estimated that:
◦ An individual with extrapulmonar TB has an increase of 86% in the risk of a recurrent
episode when compared with an individual with a pulmonary form of TB;
◦ The risk of recurrence in individuals who defaulted the treatment is 9.78 times that of
individuals who completed the treatment;
◦ An alcoholic individual has an increase of 77% in the risk of a recurrent episode when
compared with an individual without an alcoholic dependence;
◦ The risk of recurrence in individuals with HIV is 2.03 times that of individuals without
HIV;
◦ An individual with Diabetes has a decrease of 80% in the risk of a recurrent episode
when compared with someone without Diabetes;
◦ Each additional year of age is associated with an estimated 1% decrease in risk. An
additional decade corresponds to a 12% decrease.
In this case, the confidence intervals are narrow.
4.7.3 Residual Analysis
Schoenfeld Residuals
The Schoenfeld residuals were obtained for each one of the imputed datasets. In the previous
analyses, the values presented were an average of the values of the 70 imputed datasets.
However, it is computationally challenging to average all the values of the Schoenfeld residuals.
Since the imputed datasets do not differ much from each other, only one imputed dataset is
presented which is representative of the remaining imputations.
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rho χ2 p-value
CliForm=1 0.167 4.424 0.035
Sit=1 -0.460 36.876 1.3e-09
Alc=1 0.044 0.266 0.606
HIV=1 0.102 1.758 0.185
Diabetes=1 -0.125 2.263 0.133
age -0.135 2.728 0.099
GLOBAL NA 43.592 8.9e-08
Table 4.26: Test for proportionality of risks (PMM)
As expected due to the large sample size, the global value rejects the proportionality of hazards
(table 4.26). However, analysis of figure 4.27 shows that the variation in βˆ(t) for the variable
Sit is relatively close to βˆ. As previously discussed, the rejection of the proportionality is mainly
due to events that appears as outliers in the log scale (figure 4.28).
Martingale Residuals
In order to explore the fit of the models to individuals the martingale residuals were used. The
model is well fitted to the data since the residuals are evenly distributed above and under zero
(figure 4.29).
4.7.4 Collinearity
Evaluating the existence of collinearity between the covariates is essential since its existence
difficults the estimation of the coefficients. The values of VIF in table 4.27 are an average of
each imputed dataset. When the VIF is approximately 1 the covariates are independent (table
4.27).
CliForm Sit Alc HIV Diabetes age
1.065 1.125 1.068 1.150 1.007 1.033
Table 4.27: Average of the values of VIF (PMM)
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Figure 4.27: Plot of the Schoenfeld residuals (PMM)
Figure 4.28: Outliers and test for proportionality of risks (PMM)
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Figure 4.29: Plot of the martingale residuals (PMM)
4.8 Random Forest (mice)
4.8.1 Imputation Diagnosis
After the imputation, with RF, it is necessary to check if the imputed data are plausible. In
general, a good imputed value is a value that could have been observed had it not been missing.
Differences in the densities between the observed and imputed values may suggest a problem
that needs to be further checked. Figure 4.30 represents a density plot, for each imputed
dataset, of the observed and imputed values for the variable age. All the other variables
had similar distributions of imputed and observed values which does not indicate any problem
during the imputation process.
Another important diagnostics relates with the convergence of the Gibbs sampling algorithm.
Figure 4.31 represent the variables Origin, Job and Alc against the number of iterations. the
figure does not present a clear trend and the streams mingle well from the start, indicating a
good convergence.
4.8.2 Cox Regression Analysis
The variables were selected according to Collett’s approach (77), in each imputed dataset. A
variable was considered if it was significant in at least half of the models. The results presented
in table 4.28 are an average of the imputed analyses.
The variables Vac, Radio, Transf, Origin and Job were discarded from the analyses. The next
step consists of including all the significant variables in a model and remove one by one to see
its effect. Results are in table 4.29.
The variables with the lowest increase of -2 log Lˆ were removed from the model, one by one.
Afterwards, each one of the discarded variables in the univariate analysis was added to the
final model. However, since none of them significantly increased the value of -2 log Lˆ the final
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Figure 4.30: Kernel density estimates for the marginal distributions of the observed and imputed
values of the age (RF mice)
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Figure 4.31: Convergence of the Gibbs sampler (RF mice)
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Variable -2 log Lˆ p-value
Null model 2543.587 -
Vac 2541.591 0.3123
CliForm 2533.194 0.0004 ***
Radio 2541.382 0.3611
Sit 2409.896 0 ***
Sex 2538.786 0.0344 **
Origin 2543.340 0.8946
Job 2542.550 0.4365
Alc 2529.052 0.0001 ***
Smk 2511.304 0 ***
Drugs 2529.794 0.0001 ***
Prison 2537.408 0.002 ***
Commu 2537.860 0.0077 ***
Hmless 2536.050 0.0010 ***
Transf 2543.535 0.8066
Unemp 2529.851 0.0001 ***
HIV 2502.973 0 ***
Diabetes 2533.647 0.0354 **
NumCo 2531.870 0.0018 ***
age 2533.439 0.0021 ***
Table 4.28: Values of -2 log Lˆ and p-values of Likelihood ratio tests obtained in the univariate
analysis (RF mice). Signif. codes: < 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
-2 log Lˆ p-value
Model with all 2353.413 -
Model without CliForm 2360.429 0.0083 ***
Model without Sit 2451.319 0 ***
Model without Sex 2353.842 0.5170
Model without Alc 2360.480 0.0110 **
Model without Smk 2354.939 0.2401
Model without Drugs 2355.080 0.2375
Model without Prison 2357.729 0.0400 **
Model without Commu 2354.007 0.4767
Model without Hmless 2354.402 0.3338
Model without Unemp 2353.960 0.4648
Model without HIV 2358.407 0.0258 **
Model without Diabetes 2356.479 0.0800 *
Model without NumCo 2355.64 0.3300 **
Model without age 2357.403 0.0462 **
Table 4.29: Values of -2 log Lˆ and p-values of Likelihood ratio tests (RF mice). Signif. codes:
< 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
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model remained equal. The results presented in table 4.30 are a combination of the multiple
analyses through Rubin’s rules.
βˆ exp(βˆ) se(βˆ) Z p-value CI (95 %)
CliForm=1 0.624 1.866 0.235 2.653 0.0080 [0.163;1.085]
Sit=1 2.319 10.166 0.193 12 0 [1.940;2.697]
Alc=1 0.563 1.756 0.194 2.897 0.0038 [0.182;0.945]
Prison=1 1.362 3.904 0.520 2.619 0.0088 [0.343;2.380]
HIV=1 0.707 2.028 0.197 3.577 0.0003 [0.319;1.094]
Diabetes=1 -1.682 0.186 1.007 -1.671 0.0948 [-3.656;0.291]
age -0.012 0.988 0.006 -2.054 0.0400 [-0.024;-0.001]
Table 4.30: Results using the Cox model (RF mice)
The hazard ratio, exp(βˆ), was estimated for the variables (table 4.30). Adjusting for the
remaining variables, it is estimated that:
◦ An individual with extrapulmonar TB has an increase of 87% in the risk of a recurrent
episode when compared with an individual with pulmonary TB;
◦ The risk of recurrence in individuals who defaulted the treatment is 10 times the risk
that of individuals who completed the treatment;
◦ An alcoholic individual has an increase of 76% in the risk of a recurrent episode when
compared with an individual without an alcoholic dependence;
◦ The risk of recurrence in individuals incarcerated or working in a prison is 3.9 times that
of individuals who are not in the prison;
◦ The risk of recurrence in individuals with HIV is 2.03 times that of individuals without
HIV;
◦ An individual with Diabetes has a decrease of 81% in the risk of a recurrent episode
when compared with individuals without Diabetes;
◦ Each additional year of age is associated with an estimated 1% decrease in risk. An
additional decade corresponds to a 12% decrease.
4.8.3 Residual Analysis
Schoenfeld Residuals
As discussed in 4.7.3, the Schoenfeld residuals were obtained from a single imputed dataset.
Table 4.31 display the results of the test of proportionality of hazards. Although the global
value suggests nonproportionality, a visual analysis of the plots (figure 4.32) suggests that the
proportionality of hazards should not be rejected since the variation in βˆ(t) for the variable Sit
is relatively close to βˆ.
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Figure 4.32: Plot of the Schoenfeld residuals (RF mice)
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rho χ2 p-value
CliForm=1 0.1654 4.130 0.042
Sit=1 -0.4574 37.600 8.8e-10
Alc=1 0.0003 1.3e-05 0.997
Prison=1 -0.1054 1.700 0.193
HIV=1 0.1147 2.240 0.135
Diabetes=1 -0.1245 2.250 0.134
age -0.1327 2.600 0.107
GLOBAL NA 45.300 1.2e-07
Table 4.31: Test for proportionality of risks (RF mice)
Martingale Residuals
In order to explore the fit of the models to individuals, the martingale residuals were used.
The model is well fitted to the data since the residuals are evenly distributed above and under
zero (figure 4.33).
Figure 4.33: Plot of the martingale residuals (RF mice)
4.8.4 Collinearity
Evaluating the existence of collinearity between the covariates is essential since its existence
difficults the estimation of the coefficients. The values of VIF in table 4.32 are an average of
each imputed dataset. When the VIF is approximately 1 the covariates are independent (table
4.32).
CliForm Sit Alc Prison HIV Diabetes age
1.064 1.127 1.066 1.036 1.145 1.007 1.037
Table 4.32: Average of the values of VIF (RF mice)
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4.9 Random Forest (missForest)
4.9.1 Imputation Diagnosis
The package missForest does not provide visualization diagnosis to assess the plausibility of
the imputation. Nevertheless, given the closeness of results between this method and previous
methods, the imputation is likely to have performed correctly.
4.9.2 Cox Regression Analysis
One of the features of this package, is that it does not return m datasets. Instead, it returns
one imputed dataset and the analysis is made on this imputed dataset. The results of the
univariate analysis are presented in table 4.33.
Variable -2 log Lˆ p-value
Null model 2543.587 -
Vac 2540.86 0.099 *
CliForm 2533.18 0.001 ***
Radio 2539.06 0.104
Sit 2409.90 0.000 ***
Sex 2538.79 0.028 **
Origin 2543.34 0.885
Job 2542.12 0.225
Alc 2526.25 0.000 ***
Smk 2506.28 0.000 ***
Drugs 2526.19 0.000 ***
Prison 2537.54 0.014 ***
Commu 2536.59 0.008 ***
Hmless 2536.21 0.007 ***
Transf 2543.53 0.819
Unemp 2529.85 0.000 ***
HIV 2502.97 0.000 ***
Diabetes 2533.65 0.002 ***
NumCo 2531.87 0.003 ***
age 2533.40 0.001 ***
Table 4.33: Values of -2 log Lˆ and p-values of Likelihood ratio tests obtained in the univariate
analysis (RF missForest). Signif. codes: < 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
The variables Radio, Origin, Job and Transf were discarded from the analyses. The next step
consists of including all the significant variables in a model and remove one by one to see its
effect. Results are in table 4.34.
Variables with a small value of -2 log Lˆ were removed from the model individually. The
variables discarded in the univariate analysis were introduced in the final model, however, none
lead to a significant increase of -2 log Lˆ. The results are presented in table 4.35.
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-2 log Lˆ p-value
Model with all 2344.780 -
Model without Vac 2352.723 0.0048 ***
Model without CliForm 2352.203 0.0060 ***
Model without Sit 2439.601 0 ***
Model without Sex 2345.095 0.5944
Model without Alc 2351.124 0.0118 **
Model without Smk 2346.959 0.1398
Model without Drugs 2347.359 0.1083
Model without Prison 2349.410 0.0314 **
Model without Commu 2345.859 0.2989
Model without Hmless 2344.990 0.6468
Model without Unemp 2345.237 0.4990
Model without HIV 2349.034 0.0391 **
Model without Diabetes 2348.250 0.0625 **
Model without NumCo 2346.171 0.4987
Model without age 2353.603 0.0030 **
Table 4.34: Values of -2 log Lˆ and p-values of Likelihood ratio tests (RF missForest). Signif.
codes: < 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
βˆ exp(βˆ) se(βˆ) Z p-value CI (95 %)
Vac=1 0.560 1.751 0.182 3.077 0.0021 [0.203;0.917]
CliForm=1 0.661 1.937 0.234 2.825 0.0047 [0.202;1.120]
Sit=1 2.271 9.687 0.193 11.767 0 [1.893;2.648]
Alc=1 0.531 1.700 0.183 2.902 0.0037 [0.172;0.890]
Prison=1 1.348 3.848 0.518 2.602 0.0093 [0.333;2.362]
HIV=1 0.685 1.985 0.196 3.495 0.0005 [0.300;1.071]
Diabetes=1 -1.717 0.180 1.007 -1.705 0.0882 [-3.690;0.257]
age -0.020 0.980 0.007 -2.857 0.0043 [-0.034;-0.007]
Table 4.35: Results using the Cox model (RF missForest)
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The hazard ratio, exp(βˆ), was estimated for the variables (table 4.35). Adjusting for the
remaining variables, it is estimated that:
◦ An individual that was not vaccinated has an increase of 75% in the risk of a recurrent
episode when compared with a vaccinated individual;
◦ An individual with extrapulmonar TB has an increase of 94% in the risk of a recurrent
episode when compared with an individual with pulmonary TB;
◦ The risk of recurrence in individuals who defaulted the treatment is 9.69 times that of
individuals who completed the treatment;
◦ An alcoholic individual has an increase of 70% in the risk of a recurrent episode when
compared with individuals that do not drink;
◦ The risk of recurrence in individuals in prison is 3.85 times that of individuals who are
not in prison;
◦ Individuals with HIV has an increase of 99% in the risk of a recurrent episode when
compared with individuals without HIV;
◦ An individual with Diabetes has a decrease of 82% in the risk of a recurrent episode
when compared with individuals without Diabetes;
◦ Each additional year of age is associated with an estimated 2% decrease in the risk. An
additional decade corresponds to a 18% decrease.
4.9.3 Residual Analysis
Schoenfeld Residuals
The proportionality of risks was evaluated through a formal test and a visual analysis.
rho χ2 p-value
Vac=1 0.051 0.310 0.578
CliForm=1 0.172 4.419 0.035
Sit=1 -0.456 36.780 1.3e-09
Alc=1 0.029 0.121 0.728
Prison=1 -0.115 2.047 0.153
HIV=1 0.106 1.826 0.177
Diabetes=1 -0.124 2.214 0.137
age -0.163 3.616 0.057
GLOBAL NA 44.609 4.4e-07
Table 4.36: Test for proportionality of risks (RF missForest)
As expected, the global value rejects the proportionality of risks (table 4.36). However, as
discussed previously, this is mainly due to the large sample size and to the omission of important
covariates. A visual analysis reveals that the difference is not important (figure 4.34).
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Figure 4.34: Plot of the Schoenfeld residuals (RF missForest)
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Martingale Residuals
In order to explore the fit of the models to individuals, the martingale residuals were used.
The model is well fitted to the data since the residuals are evenly distributed above and under
zero (figure 4.35).
Figure 4.35: Plot of the martingale residuals (RF missForest)
4.9.4 Collinearity
The collinearity between covariates was also evaluated. When the VIF is approximately 1 the
covariates are independent (table 4.37).
Vac CliForm Sit Alc Prison HIV Diabetes age
1.191 1.060 1.121 1.077 1.041 1.134 1.007 1.077
Table 4.37: Values of VIF (RF missForest)
4.10 Expectation-Maximization with Bootstrapping
4.10.1 Imputation Diagnosis
The package Amelia II provides several diagnostic plots, useful to check the plausibility of the
imputed data. One diagnostic tool is to compare the distribution of imputed values with the
distribution of observed values (figure 4.36). Although no knowledge exists a priori about the
distribution of missing values, imputations with different distribution or very distant from the
distribution of observed data may indicate that the imputation model needs improvements.
Another useful diagnostic is to check the convergence of the imputation. Amelia II provides
a function to make sure the imputations do not depend on the starting values. In this sense,
the EM algorithm is run from multiple, dispersed starting values. Figure 4.37 shows a well
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Figure 4.36: Distribution of mean imputations (in red) overlayed on the distribution of observed
values (in black) for several variables (EMB)
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behaved likelihood, since the starting values converged to the same value, and therefore, it is
reasonable to conclude that this is the likely global maximum. Th Y-axis represents movement
in the parameter space while the X-axis represents the number of chain iterations.
Figure 4.37: Overdispersion diagnostic (EMB)
4.10.2 Cox Regression Analysis
As mentioned in section 3.1.3, the analysis should be done in each imputed dataset and not
only on the pooled data. Therefore, the selection of variables was realized in each of the
imputed dataset. A variable was considered if it was significant in at least half of the models.
The results presented in table 4.38 are an average of the imputed analyses.
The variables Radio, Origin, Job and Transf were discarded from the analyses. The next step
consists in including all the significant variables in a model and remove one by one to see its
effect. Results are in table 4.39.
One by one the variable with the lowest increase of -2 log Lˆ was removed from the model.
Sex, Hmless, Unemp, Commu, Drugs, Smk and NumCo were discarded due to the low value
of -2 log Lˆ. The next step consists of adding each of the discarded variables in the univariate
analysis to the complete model. None of the discarded variables had a significant increase of -2
log Lˆ. The results presented in table 4.40 are a combination of the multiple analyses through
Rubin’s rules.
The hazard ratio, exp(βˆ), was estimated for the variables (table 4.40). Adjusting for the
remaining variables, it is estimated that:
◦ An individual that was not vaccinated has an increase of 56% in the risk of a recurrent
episode when compared with a vaccinated individual;
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Variable -2 log Lˆ p-value
Null model 2543.587 -
Vac 2535.981 0.0642 *
CliForm 2533.198 0.0004 ***
Radio 2540.687 0.1127
Sit 2409.896 0 ***
Sex 2538.786 0.0344 **
Origin 2543.374 0.6657
Job 2542.319 0.4325
Alc 2526.303 4.1e-05 ***
Smk 2508.066 3.2e-10 ***
Drugs 2524.292 1.6e-05 ***
Prison 2524.292 0.0077 ***
Commu 2536.725 0.0095 ***
Hmless 2537.032 0.0043 ***
Transf 2543.535 0.8066
Unemp 2529.851 6.8e-05 ***
HIV 2502.973 9.7e-13 ***
Diabetes 2533.647 0.0354 **
NumCo 2535.952 0.0034 ***
age 2533.441 0.0021 ***
Table 4.38: Values of -2 log Lˆ and p-values of Likelihood ratio tests obtained in the univariate
analysis (EMB). Signif. codes: < 0.01 ’***’ 0.05 ’**’ 0.1 ’*’
-2 log Lˆ p-value
Model with all 2349.01 -
Model without Vac 2355.92 0.092 *
Model without CliForm 2355.516 0.011 **
Model without Sit 2440.447 0 ***
Model without Sex 2349.409 0.539
Model without Alc 2354.942 0.027 **
Model without Smk 2350.534 0.282
Model without Drugs 2350.333 0.353
Model without Prison 2352.533 0.117
Model without Commu 2349.982 0.420
Model without Hmless 2349.454 0.600
Model without Unemp 2349.327 0.589
Model without HIV 2355.036 0.015 **
Model without Diabetes 2351.788 0.096 *
Model without NumCo 2350.071 0.309
Model without age 2355.414 0.015 **
Table 4.39: Values of -2 log Lˆ and p-values of Likelihood ratio tests (EMB). Signif. codes: <
0.01 ’***’ 0.05 ’**’ 0.1 ’*’
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βˆ exp(βˆ) se(βˆ) Z p-value CI (95 %)
Vac=1 0.443 1.557 0.255 1.737 0.0836 [-0.059;0.946]
CliForm=1 0.62 1.859 0.237 2.61 0.0091 [0.154;1.085]
Sit=1 1.118 3.059 0.099 11.272 0 [0.924;1.312]
Alc=1 0.531 1.701 0.198 2.681 0.0074 [0.143;0.92]
Prison=1 1.056 2.875 0.55 1.921 0.055 [-0.023;2.135]
HIV=1 0.66 1.935 0.2 3.297 0.001 [0.267;1.052]
Diabetes=1 -1.682 0.186 1.007 -1.669 0.0951 [-3.656;0.293]
age -0.017 0.983 0.006 -2.547 0.0109 [-0.029;-0.004]
Table 4.40: Results using the Cox model (EMB)
◦ An individual with an extrapulmonary form of TB has an increase of 86% in the risk of
a recurrent episode when compared with an individual with pulmonary form of TB;
◦ The risk of recurrence in individuals who defaulted the treatment is 30.6 times that of
individuals who completed the previous treatment;
◦ An alcoholic individual has an increase of 70% in the risk of a recurrent episode when
compared with an individual that is not alcoholic;
◦ The risk of recurrence in individuals incarcerated or working in a prison is 2.88 times
that of individuals who are not in a prison;
◦ An individual with HIV has an increase of 94% in the risk of a recurrent episode when
compared with an individual without HIV;
◦ An individual with Diabetes has a decrease of 81% in the risk of a recurrent episode
when compared with an individual with Diabetes;
◦ Each additional year of age is associated with an estimated 2% decrease in risk. An
additional decade corresponds to a 16% decrease.
It is important to observe than the confidence intervals are small, capturing a smaller range of
effect sizes.
4.10.3 Residual Analyses
Schoenfeld Residuals
As discussed in 4.7.3, the Schoenfeld residuals were obtained for one imputed dataset.
The global value rejects the proportionality of risks (table 4.41), this is not unexpected since
the sample size is quite large. Figure 4.38 shows that the variation in βˆ(t) is relatively close
to βˆ. The omission of important covariates can also be responsible for the presence of non-
proportionality.
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Figure 4.38: Plot of the Schoenfeld residuals (EMB)
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rho χ2 p-value
Vac=1 0.104 1.552 0.213
CliForm=1 0.159 3.858 0.050
Sit=1 -0.455 38.198 6.4e-10
Alc=1 0.018 0.047 0.828
Prison=1 -0.115 1.990 0.158
HIV=1 0.114 2.212 0.137
Diabetes=1 -0.126 2.280 0.131
age -0.160 3.723 0.054
GLOBAL NA 47.067 1.5e-07
Table 4.41: Test for proportionality of risks (EMB)
Martingale Residuals
In order to explore the fit of the models to individuals the martingale residuals were used.
Similarly with the Schoenfeld residuals, the plot will be presented based in the same imputed
dataset. The model is well fitted to the data since the residuals are evenly distributed above
and under zero (figure 4.39).
Figure 4.39: Plot of the martingale residuals (EMB)
4.10.4 Collinearity
The collinearity between covariates was also evaluated. When the VIF is approximately 1 the
covariates are independent (table 4.42).
Vac CliForm Sit Alc Prison HIV Diabetes age
1.103 1.069 1.147 1.086 1.041 1.158 1.007 1.112
Table 4.42: Average of the values of VIF (EMB)
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4.11 Comparison between models
Table 4.43 summarizes the results obtained in each of the imputation methods that were used.
The main results were grouped in a table for a better visualization and interpretation.
Through table 4.43 it can be observed that the use of different imputation tecnhiques did not
change the direction of the parameter estimates and showed good consistency. In general,
CC showed wider CI and larger standard error of the coefficient estimates than the other
methods. CC did not positively associated Alcohol and Diabetes to recurrence, most likely due
to the small sample size. Looking at each variable individually, the variable Vaccine was only
selected using CC, mean imputation, EMB and RF missForest. This variable produced the
most controversial results since it was only selected by these methods. CliForm was selected
in all methods, the coefficient estimate and standard error is higher for CC and CC without
Vaccine. The remaining imputation methods produced outputs that were rather similar. A
similar behaviour was observed with the variable Sit. The estimates presented higher values for
the methods CC and CC without Vac. Mean imputation, PMM, RF missForest and RF mice
had similar values but EMB had a considerable smaller value for the coefficient estimate and its
standard error. Only the CC analysis did not select the variable Alc, the other methods yielded
similar values, with a higher value in the case of CC without Vac. Only the method PMM did
not select the variable Prison. As previously, similar values were obtained for all the methods
but CC has higher values due to the smaller sample. Compared with the other variables, Prison
has a wider CI. The variable Commu was only selected for CC without Vac. HIV was selected
in all methods, execpt for CC without Vac. Similar values were obtained, with higher values
for the estimates in the CC analysis. Due to the issue of monotone likelihood, the variable
Diabetes was not included in the CC analysis; however, it was selected in all the remaining
methods. Similar values were obtained for this variable. It should be noted that Diabetes has
the widest CI and highest standard error obtained in the imputation methods. The variable
age was included in all models and the values showed a remarkable similarity between all the
methods.
All the methods used yielded a low value of R2, although in survival analysis values significantly
smaller than 0.5 are usual. Values close to 1 are unlikely since it would mean that the model,
in this case, would predict the exact day of the recurrence of TB. The values of R2 are similar,
although the value of R2 obtained in the complete case analysis is slightly higher. Regarding
the concordance index, which basically means that by randomly selecting two observations, the
one with lower survival time is also the one that has the highest estimated risk, show similar
results. All the models showed very good results with CC presenting slightly higher values.
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Variables
CC
CC
wtVac
M
ean
PM
M
RF
m
ice
RF
m
issForest
EM
B
β
(se(β))
β
(se(β))
β
(se(β))
β
(se(β))
β
(se(β))
β
(se(β))
β
(se(β))
width(CI)
width(CI)
width(CI)
width(CI)
width(CI)
width(CI)
width(CI)
Vac
0.590
(0.320)
-
0.544
(0.204)
-
-
0.560
(0.182)
0.443
(0.255)
2.450
-
0.800
-
-
0.714
1.005
CliForm
0.950
(0.450)
0.803
(0.302)
0.668
(0.235)
0.634
(0.235)
0.624
(0.235)
0.661
(0.234)
0.620
(0.237)
5.190
1.184
0.920
0.923
0.922
0.918
0.931
Sit
2.560
(12.98)
2.640
(0.226)
2.302
(0.192)
2.280
(0.193)
2.319
(0.193)
2.271
(0.193)
1.118
(0.099)
18.970
0.886
0.755
0.757
0.757
0.755
0.388
Alc
-
0.532
(0.233)
0.589
(0.191)
0.574
(0.195)
0.563
(0.194)
0.531
(0.183)
0.531
(0.198)
-
0.913
0.747
0.764
0.763
0.718
0.777
Prison
2.330
(0.740)
1.714
(0.599)
1.433
(0.518)
-
1.362
(0.520)
1.348
(0.518)
1.056
(0.550)
40.940
2.346
2.032
-
2.037
2.029
2.158
Com
m
u
-
1.076
(0.395)
-
-
-
-
-
-
1.548
-
-
-
-
-
HIV
1.190
(0.360)
-
0.752
(0.197)
0.706
(0.198)
0.707
(0.197)
0.685
(0.196)
0.660
(0.200)
5.050
-
0.773
0.776
0.775
0.771
0.785
Diabetes
-
-1.425
(1.009)
-1.660
(1.007)
-1.680
(1.007)
-1.682
(1.007)
-1.717
(1.007)
-1.682
(1.007)
-
2.849
3.949
3.360
3.947
3.947
3.949
age
-0.030
(0.010)
-0.013
(0.007)
-0.014
(0.986)
-0.013
(0.006)
-0.012
(0.006)
-0.020
(0.007)
-0.017
(0.006)
0.050
0.027
0.006
0.024
0.023
0.027
0.025
R
2
0.1173
0.0864
0.0854
0.0798
0.0822
0.0863
0.0851
C
0.8168
0.7779
0.7952
0.7912
0.7913
0.7945
0.7948
−
2logLˆ
624.640
1534.135
2354.097
2366.683
2361.307
2352.176
2354.901
Tim
e
-
-
0m
1.228s
27m
35.431s
1560m
12.561s
5m
59.843s
2m
18.997s
Table
4.43:Resultsobtained
with
the
Cox
m
odelforallthe
differentm
ethods
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Discussion
The main goal of this thesis was to analyze recurrent cases of TB, in order to identify covariates
that affect the time from the end of the first episode until the beginning of the second episode.
To achieve this purpose, data from the SVIG-TB database was analyzed. Only patients diag-
nosed with their first episode of TB between 2002 and 2009, in Portugal, were included. The
BCG vaccination was one of the most interesting variables to include in the analysis due to the
long-lasting discussion about the protective effect of the vaccine. However, using this variable
leads to a problem concerning the amount of missing data in the dataset. In fact, missing
data ranged from a low value of 0.03% for Clinical Form to a high value of 59% for Vaccine.
One possible explanation for the different amount of missing data is that each health center or
health unit ask questions to the patient and uploads the information to the SVIG-TB. Since
probably, some centers give more importance to some variables while others disregard them,
this has led to many missing values in the current dataset.
Faced with this scenario, two options were possible. Drop all individuals with missing infor-
mation and perform a complete case analysis only on one third of the data or impute the
missing data and use all the available information. However, the literature advises against
using complete case analysis in the presence of MAR data since complete case analysis yields
biased results (52; 53). Therefore, it is important to explore and understand the missing data.
The exploratory analyses suggested an association between some variables and the missingness
of values of other variables. Although it is impossible to prove if the data are MAR or MNAR,
this association suggests that the data may be MAR. Hence, the best course of action was
to impute the missing data through techniques of multiple imputation. A model was fitted
to the complete dataset in order to compare the results with the results obtained by models
fitted to imputed datasets. A model was fitted to the complete dataset without the variable
Vaccine in order to understand the implications of discarding a variable with a large proportion
of missing data. A "complete" dataset was obtained through mean imputation in order to
compare the results of single imputation with multiple imputation. Several methods were used
in multiple imputation: Predictive Mean Matching, two different models of Random Forest
and a model of Expectation-Maximization with Bootstrapping. Predictive Mean Matching
presents, in general, consistent results in literature. Recent research (67) argues that there
is an advantage in imputing data with Random Forest and Expectation-Maximization with
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Bootstrapping imputes data via the maximum likelihood.argues about the value of imputing
data with RF and a model of EMB, which imputes data via the maximum likelihood.
The difference in the results between the model fitted to the complete dataset without the
Vaccine and all the others models is striking. The model fitted to the complete dataset without
the Vaccine was the only model that selected the variable Residence Community and the only
one that discarded the variable HIV, which is frequently associated with recurrence in TB in
the literature (29; 30; 98). Although the model has a good value of R2, compared with the
models obtained by imputation, this value is obtained only in a subset of the dataset. This
subset does not seem to be appropriate to correctly infer about the population, since the
results are not consistent with the other models. Extreme attention should be taken when one
decides to remove a variable and perform a complete case analysis on the remaining variables,
especially if the effect of the variable is unknown or important.
There were some differences between the models regarding the selection of variables. The
variable Alcohol and Diabetes were not significant in the model fitted to the complete dataset,
the latter was excluded from the model due to a problem of monotone likelihood. The models
obtained from the "complete" dataset generated by mean imputation, RF missForest and
EMB included the same variables (Vac, CliForm, Sit, Alc, Prison, HIV, Diabetes and age). The
model used with the dataset obtained by PMM discarded the variable Prison and Vaccine. The
results of the variable Vaccine were the most inconsistent. This variable was only significant
in CC, mean imputation, RF missForest and EMB.
As expected, the coefficient estimates and standard errors of the model fitted to the complete
dataset are higher than the ones from imputation. Although the values of R2 and C are higher
than in the models fitted to imputed datasets these values cannot be correctly compared since
the models are based on different subset of individuals. The coefficient estimates and standard
errors, between single and multiple imputation, are very similar, except for a slight increase
of the coefficient estimate for the variable Prison. However, as previously discussed, mean
imputation does not introduce variability into the model, ignoring that the values are not
all true. Mean imputation results in small standard errors and in unbiased estimates but
overestimates the precision (43; 54; 55), which could explain the high value of R2 and C,
compared with the value obtained for the datasets imputed by multiple imputation.
The model fitted to the data imputed by PMM is the only model, compared with the models
obtained by multiple imputation techniques, that has not selected the variable Prison. Of
all the models fitted to the data obtained from multiple imputation, it has the lower value
of R2 and C, although the results for the other variables are consistent and similar to the
remaining models. Comparing the models fitted to the data imputed by techniques of RF, the
coefficient estimates and standard errors seem similar and are consistent. Recent research (67)
suggests thatmice RF performs better thanmissForest, since the latter replaces missing values
with predicted values rather than draw from a distribution, which leads to biased parameter
estimates. However, in this case, the results obtained by these two RF techniques are similar
and the major disadvantage of the mice package is that the imputation is much slower than
with the package missForest. The value of −2logLˆ is lower in the model imputed by RF
missForest, and the values of R2 and C are slightly higher in this model. Regarding the
measures of explained variation, the model fitted to the data imputed by EMB has a slightly
higher value of R2 and C, compared with the other models obtained by multiple imputation,
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and the value of the statistic −2logLˆ is slightly lower than with the models imputed by PMM
and RF mice. The fact that the standard errors are smaller in the models fitted to imputed
datasets is an indicator of a good performance of the imputation methods. Although the value
of R2 is smaller in the models fitted to the imputed datasets, compared with the value of the
model fitted to the complete dataset, these values should not be compared since the subset in
analysis is different, which only means that for that subset the complete case analysis performs
relatively well.
Overall, the results obtained with the different techniques are similar. In hte case of a variable
with more than 30% of missing observations it is recommend to use multiple imputation
instead of single imputation. Of the four techniques used, PMM seems to present the least
promissing results, since the variable Prison, included in the remaining models, was not included
in this model and although, the coefficient estimates and standard errors obtained are not very
different from the other models, the values of the measures of explained variation used are
worse. The R2 is the lowest value of R2 among the imputed models, and the value of the
statistic −2logLˆ is higher compared with the remaining models. Comparing the models fitted
to the data imputed by the RF techniques and EMB, they seem to present similar results,
except for the model fitted to the dataset imputed by RF mice that did not included the
variable Vac. Among these three techniques, RF mice has a slighlty lower value of R2 and a
higher value of the statistic −2logLˆ. However, the major drawback of this technique is the
time to execute the function, which is significantly larger than any of the two other methods.
Although the package missForest has been previously associated with biased estimates (67),
it does not seem to be the case in this study since the results are similar to RF mice. The
results obtained from a imputed dataset by EMB and RF missForest are similar, although the
imputation by EMB has produced slight differences in the coefficient estimates and standard
errors. The values of C, R2 and of the statistic −2logLˆ are similar.
Under these conditions, both EMB and RF missForest seem to produce adequate results. It is
not possible however, to select the "best" technique to impute missing data. Before imputing
data, each dataset should be treated independently. A series of choices (such as the number of
imputed datasets, the number of iterations, the method or methods to impute the data, how
to incorporate interactions or non-linearities, etc) should be considered and they need to be
treated carefully since wrong options could lead to incorrect estimates. Most software packages
for multiple imputation have defaults for many of these points. However, these choices are
not trivial and the user should carefully consider if the defaults are appropriate for his dataset.
The literature has increased on this subject and many articles enlight the user about the most
appropriate method for his dataset. However, most of the times, these studies are based on
simulation studies. These are based on fully generated data that use models based on limited
structures of the population to generate datasets that do not fully reflect a realistic population
even if the attributes are based on real datasets (53).
After modelling the data, it is necessary to analyse the results. There are many challenges in
managing and controling TB, including prompt diagnosis, effective treatment and successful
prevention strategies. One serious problem is the recurrence of tuberculosis. The patient has
to go through another round of treatment, which in some countries is more toxic, takes longer
to complete and may amplify drug resistance.
Many studies argue about the protection of the BCG vaccine and its efficacy in preventing
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pulmonary TB in adults. However, most of them just ignore this issue and do not include
information about the BCG vaccine in their analysis. Other studies concer to the presence or
absence of a BCG scar; however, the absence of a scar does not confirm the lack of vaccination.
Due to this current discussion about the effect of the BCG vaccine, this variable was included
in the model to assess its importance and role in recurrence. The estimated effect for the
BCG vaccine ranges from 56% (model fitted by EMB imputation) to 80% (complete case
analysis). The results obtained are mixed, since Vaccine was significant in some models and
discarded in others. Nevertheless, they all point to an increase of more than 50% in the risk
of recurrence, for an individual not vaccinated compared with someone vaccinated. Given that
the vaccine efficacy declines with time (15 years after the vaccination the effect is negligible)
further studies would need to be done to fully understand the efficacy of BCG and its role in
recurrence.
The inclusion of the clinical form in a study about recurrence is unsual. The majority of studies
discard the cases of extrapulmonary TB and performs the analysis only on the pulmonary cases.
A reason for this could be that the proportion of extrapulmonary TB, in developed countries,
is low (in this dataset the proportion of extrapulmonary TB is 8.4%) and less infectious than
pulmonary TB. However, diagnosing extrapulmonary TB is not straightforward, since the clin-
ical presentations (central nervous system, lymphatic system, genitourinary system, bones and
joints, among others) are atypical and simulate other inflammatory and neoplasic conditions.
This results in delay in treatment since it is necessary a high level of suspicion to make an early
diagnosis. Past history of TB is frequently associated with pulmonary TB, although studies
to determine if this is a result of reinfection or relapse are missing. However, a study in Nepal
(99), which is a high-burden country, compared pulmonary and extrapulmonary TB and found
that, after a primary infection in the lungs, the probability of reactivation at an extrapulmonary
site could be higher at younger age, while reactivation of TB in the lungs was more common
at older ages.
An individual that defaulted the previous treatment had between 3 times (in the model fitted
to the dataset imputed by EMB) to 9 times (similar values for the remaining models) the risk
to have a recurrent episode of someone who completed the treatment. This is not unexpected
since someone who defaulted the treatment is likely to still be infected and therefore should
continue the treatment later on. However, the study from Nepal (99) suggests that the
retreatment could be due to extrapulmonary TB since the disease would have spread outside
the lungs. Identifying patient characteristics that confer higher risk of default from primary
TB treatment may help to establish prevention strategies to reduce the need for retreatment.
The results for the variable Alcohol were consistent for all the implemented models. An
alcoholic individual has between 70% and 80% the risk to have a recurrent episode than
someone who is not alcoholic. However, alcoholism has been identified as a predictor for
treatment noncompliance (100). Treatment noncompliance is responsible for poor results in
treatment, death, default and recurrence. Picon (100) studied risk factors for recurrence and
found that alcoholism was more common among patients with poor adherence to treatment.
In fact, when information about alcohol abuse and treatment noncompliance was included,
alcohol abuse was no longer significant. The dataset analysed in this thesis did not had
information about treatment noncompliance. Therefore, it seems that the variable alcohol
may be a confounding factor, since it is related with treatment noncompliance and treatment
noncompliance is a risk factor for recurrence.
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Being incarcerated or working in a prison is a known risk factor for infection with TB. This
is mainly due to overcrowding, late diagnosis and inadequate treatment (39; 40). The coeffi-
cient estimates obtained for this variable are more diverse, the risk of recurrence for someone
incarcerated ranged from almost 3 times (model fitted to the dataset imputed by EMB) to 10
times (complete case analysis) that someone who is not in prison. The influence of this vari-
able is mixed in the literature, where some studies argues its significant impact in recurrence
while others do not find a significance. More research will need to be done to understand its
association or lack of association and understand how the variable Prison relates to treatment
noncompliance. Campani (101) studied the variables associated with treatment noncompliance
and found a positive association with prison. However, only in cases where the patient escaped
from the jail. Although it is expected that individuals in prison are more controlled with their
medications than outside prison, our results suggest that this is not the case in Portugal. The
problem of overcrowding and lack of good resources could be influential factors for treatment
noncompliance and recurrence.
As expected, HIV was positively associated with recurrence of disease. The research focus on
HIV patients due to their weak immunity system. In this study, only a variable Yes/No about
whether the patient has HIV was included. It would have been interesting to add information
about the severity of immunosuppression since it is also a predictor of TB recurrence (102).
The results of the coefficient estimates of Diabetes were not expected. This analysis showed
that individuals with Diabetes have a decrease of 80% in the risk of a recurrent episode
compared to individuals without Diabetes. This is the same to say that someone without
Diabetes has an increase of 20% in the risk of a recurrent episode when compared with someone
with Diabetes. Some studies report a positive association with Diabetes while others do not.
Those who reported an association between recurrence and Diabetes always found a higher
risk to have a recurrent episode of TB between individuals with Diabetes. However, these
results should be interpreted bearing in mind the proportion of undiagnosed individuals with
Diabetes. Some collaborators, of the Collective Dynamics Group at the Instituto Gulbenkian
de Ciência, based in Brazil found a rate of 30% of undiagnosed individuals with Diabetes.
In Portugal, Gardete-Correia (103), from the Portuguese Diabetes Association, estimated a
proportion of 43% of undiagnosed individuals with Diabetes. This number is high and could
lead to an underestimation of the true effect of the variable Diabetes in the recurrence of TB.
Furthermore, Diabetes can have a confounding effect with treatment noncompliance, since
individuals with Diabetes are used to prolonged daily intake.
Age is a risk factor for TB infection. However, only in some studies a positive association
between recurrence and age was found. In this study, an increase of one year in the age of
a patient leads to a decrease of around 1% to 2% in the risk of a recurrent episode. Some
articles refer older age as a risk factor, which is correlated with a weaker immune system.
Younger patients were sometimes associated with relapse. Picon (100) found that age was a
confounding factor since it was related with treatment noncompliance. In fact, noncompliance
was higher among younger patients. Since information abut treatment noncompliance was not
included in the model, age could be acting as a confounding factor.
It is clear from the discussion that the dataset lacks important variables, such as, treatment
noncompliance, which has been show to play an important role in recurrence, MDR (Multi
Drug Resistance) infection, that was also associated with recurrence, especially among HIV
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patients, and stage of the disease when starting treatment.
Some variables were not signicant in this study, but are frequently positively associated with
recurrence. Smoking was not significant in this study, although some found a positive as-
sociation. However, those studies also fail to include important variables such as treatment
noncompliance. Male patients were also found associated with recurrence in some studies.
However, this exploratory analysis suggests that these results could be due to a confounding
factor, since, in this study, there is a higher proportion of males with HIV, alcoholic problems,
smoker, etc., than females with HIV, alcoholic problems, etc.
In countries of low incidence, recurrence is usually attributed to relapse, while in countries of
high incidence, the recurrence is mainly due to reinfection. Recurrence due to reinfection is a
constant risk over time, whereas recurrence due to relapse seem to occur closer to the end of the
first treatment. In this study, 55% of the cases of recurrence occurred in the first 12 months.
The characteristics associated with recurrence seem to indicated that these cases may be due
to relapse. HIV, an extrapulmonary form of TB and younger age are some of the characteristics
frequently associated with relapse. Extrapulmonary TB is also less common among diabetic
TB patients. Incomplete bacteriological cure, usually caused by irregular medication intake,
is also a common cause of relapse. Some collaborators, of the Collective Dynamics Group at
the Instituto Gulbenkian de Ciência, based in Brazil have found cases of reinfection 10, 20 and
even 36 years after the first episode of TB. Future studies should consider longer follow-up
times and inclusion of DNA information in order to properly distinguish between relapse and
reinfection.
This study has some limitations, especially due to variables that were not available. Most
questions are answered by the patient who may lie about important variables, such as drug
and alcohol abuse, smoker, etc, introducing bias in the analysis. A possible solution for the
missing variables would be a frailty model. A frailty model is a random effects model and it
can be used to describe the influence of unobserved covariates not included in a proportional
hazards model. Nevertheless, compared with the majority of studies made on TB, this study
has the larger dataset studied. The sample size studied is frequently below 1000 individuals.
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Conclusion
This study reported risk factors associated with recurrence, in Portugal. Overall, not being vac-
cinated, having extrapulmonary infection, having defaulted treatment, being alcoholic, prison
inmate or HIV positive are risk factors for TB recurrence. However, it is likely that some
of these variables are correlated to variables that were not measured, particularly, treatmente
noncompliance and the stage of the disease when starting treatment. Interestingly, having
Diabetes and being of an older age confer protection against TB recurrence. These results
suggests that the majority of the recurrence cases may be due to relapse since extrapulmonary
TB, younger age and HIV are associated with relapse. Usually, relapse occurs closer to the
end of the treatment while reinfection can occur over the time. However, a longer study
with genotyping information should be performed to confirm these results. Few studies are
performed on portuguese data and more studies would be needed to confirm these results.
Imputation was an important option to obtain the results. Deleting the missing observations
would have led to biased estimates and loss of information due to the discarded individuals.
Some researchers avoid imputation because of fear of "making up data" but they forget that
complete case analyses require stronger assumptions than imputation does.
Before performing the imputation, the user needs to understand the type of missing data and
the best methods to impute his dataset. Inadequate handling of the missing data in a statistical
analysis can lead to biased or inefficient estimates. As a result, the first time user may get lost
in a labyrinth of imputation methods. A proper review of the literature will shed some light into
the different techniques to impute data and the most appropriate for his scenario. However, the
best imputation approach remains unclear. In this thesis, both techniques of Random Forest
performed well, although the package mice is very slow. Imputation via maximum likelihood
also presented satisfactory results.
Inclusion of information about treatment noncompletion, drug resistance and genotyping data
(to distinguish between relapse and reinfection) is essencial. A possible solution for the missing
variables would be a frailty model. A frailty model is a random effects model and it can be
used to describe the influence of unobserved covariates not included in a proportional hazards
model.
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Appendix A
The aim of this appendix is to display the main functions created. The code necessary to
obtain the results are also displayed below. Table A1 state the main R functions used.
Statistical Analysis Function Library Reference
Analysis of missing data
naclus Hmisc (104)
naplot Hmisc (104)
aggr VIM (105)
LittleMCAR BaylorEdPsych (92)
Firth’s penalized likelihood logistf logistf (95)coxphf coxphf (97)
Survival Analysis
Cox models coxph survival (106)cph rms (107)
Residuals cox.zph survival (106)resid stats (88)
Collinearity vif rms (107)
Predictive ability validate rms (107)
Discrimination validate rms (107)
Imputation
Mean imputation na.roughfix randomForest (108)
EMB
amelia Amelia II (74)
disperse Amelia II (74)
imputationList mitools (109)
MICE mice mice (61)quickpred mice (61)
RF mice mice (61)missForest missForest (110)
Table A1: R functions available in CRAN
Functions developed
# This function is used to calculate the value of -2 log
Likelihood for models without imputation - not of mids
class
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# To use this function make sure to name your dataset
completeImp
# This function returns a data frame with all the variables
and the respective value of - 2 log Likelihood and the
p-value
firstCollett <- function(x) {
mod <- coxph(Surv(time , status) ~ completeImp[,x], data=
completeImp)
logL <- -2 * mod$loglik [2]
p <- anova(mod , test = "Chisq")$Pr[2]
resp <- data.frame(logL , p)
names(resp) <- c(" -2 log L","Pvalue")
return (resp)
}
# This function is used to calculate the value of -2 log
Likelihood for models imputed with Amelia - Package
Mitools was used to convert the data to an appropriate
format for analysis
# To use this function make sure to name your dataset
impData
# This function returns a data frame with the value of -2
log Likelihood for the null model and a model with
variables , the p-value for the likelihood ratio test is
also returned - for each m dataset a value is calculated
.
firstCollettAmelia <- function(mod , anovaImp , m) {
logLnull <- NULL
logLcomp <- NULL
p <- NULL
for (k in 1:m) {
fit <- mod[[k]]
logLnull[k] <- -2 * fit$loglik [1]
logLcomp[k] <- -2 * fit$loglik [2]
p[k] <- anovaImp [[k]][5]
}
vals <- data.frame(logLnull , logLcomp , p)
return (vals)
}
# Function to help compute the values of -2logL for the
second and third step of Collett method of selection
of variables
secondCollettAmelia <- function(mod , modf , m) {
logLcomp <- NULL
test <- NULL
p <- NULL
for (k in 1:m) {
fit <- mod[[k]]
fitFull <- modf[[k]]
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logLcomp[k] <- -2 * fit$loglik [2]
test <- lrtest(fitFull , fit)
p[k] <- test$stats [3]
}
vals <- data.frame(logLcomp , p)
return(vals)
}
# This function is used to calculate the value of -2 log
Likelihood for models imputed with mice
# To use this function make sure to name your dataset imp
# This function returns a data frame with the value of -2
log Likelihood for the null model and a model with
variables , the p-value for the likelihood ratio test is
also returned - for each m dataset a value is calculated
.
firstCollettMI <- function(mod , anovaImp , m) {
logLnull <- NULL
logLcomp <- NULL
p <- NULL
for (k in 1:m) {
fit <- mod$analyses [[k]]
logLnull[k] <- -2 * fit$loglik [1]
logLcomp[k] <- -2 * fit$loglik [2]
p[k] <- anovaImp$analyses [[k]][5]
}
vals <- data.frame(logLnull , logLcomp , p)
return (vals)
}
# Function to help compute the values of -2logL for the
second and third step of Collett method of selection of
variables for mice
secondCollettMI <- function (mod , modf , m){
logLcomp <- NULL
test <- NULL
p <- NULL
for (k in 1:m) {
fit <- mod$analyses [[k]]
fitFull <- modf$analyses [[k]]
logLcomp[k] <- -2 * fit$loglik [2]
test <- lrtest(fitFull , fit)
p[k] <- test$stats [3]
}
vals <- data.frame(logLcomp , p)
return (vals)
}
# This function calculates the VIF for each imputed dataset
and returns a single vector with the average of the VIF
in all imputed datasets
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collinearity <- function(modf , m) {
col <- NULL
for (k in 1:m) {
col[[k]] <- vif(modf$analyses [[k]])
}
vifs <- as.data.frame(do.call("rbind", col))
return (colMeans(vifs))
}
# This function calculates the R^2 for each imputed dataset
and returns a single vector with the average of the R^2
in all imputed datasets
squareR <- function(modf , m) {
r <- NULL
for(i in 1:m) {
r[i] <- modf$analyses [[i]]$stats [8]
}
return (mean(r))
}
# This function calculates the concordance index for each
imputed dataset and returns a single vector with the
average of the concordance index in all imputed datasets
concordance <- function(modf , m) {
cHarrell <- NULL
for (i in 1:m) {
cHarrell [[i]] <- validate(modf$analyses [[i]], dxy=TRUE ,
B=1)
}
#get first element (Dxy) of index.origin
listC <- lapply(cHarrell , ‘[[‘, 1)
return (abs(mean(unlist(listC)))/2+0.5)
}
Complete case analysis
#remove all observations with missing values
completeImp <- data1[complete.cases(data1),]
#calculate the value of -2 log Likelihood for the null
model
modNul <- coxph(Surv(time , status) ~ 1, data=completeImp)
# index of the columns in the dataframe
vars <- c
(1,2,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19,20,23)
data.frame(variable = names(completeImp[vars]), t(sapply(
vars , firstCollett)))
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To obtain the final model, the value of -2 log L of a reduced model was calculated manually
and the p-value obtained compared the reduced model with the complete model. The code
below is an example of the process of selection variables.
modComp <- coxph(Surv(time , status) ~ Sit + HIV + Prison +
Vac + age + CliForm , completeImp)
comp <- -2 * modComp$loglik [2]
modReduce <- coxph(Surv(time , status) ~ Sit + HIV + Prison
+ Vac + age + CliForm + Radio , completeImp)
partial <- -2 * mod1$loglik [2]
anova(modReduce , modComp , test="Chisq")
Mean imputation
Only the function used to replace the missing values by the median of each variable is present,
since the rest of the analysis is identical to the one presented in the Complete case section.
completeImp <- na.roughfix(data1)
EMB imputation
set.seed (72108)
#create matrix to give information about positive numeric
variables
#In this case , Symp (data1 [ ,20]) and age (data1 [,22])
have been atributed the lower value to 0 and the
highest value correspond to the maximum value of the
respective variable
posNum <- matrix(c(20 ,22 ,0 ,0 ,624 ,100), nrow=2, ncol =3)
amelia <- amelia(data1 , m=70, noms=c("Vac", "CliForm", "
Radio", "Sit", "Sex", "Origin", "Job", "Alc", "Smk", "
Drugs", "Prison", "Commu", "Hmless", "Transf", "Unemp"
, "HIV", "Diabetes", "NumCo", "status"), bound=posNum)
The following code is just a demonstration to use the function firstCollettAmelia. This step
was not automated therefore, these lines need to be run for each variable. An example is
displayed below.
mod <- with(impData , cph(survmod ~ Vac , x=T, y=T))
anovaImp <- with(impData , anova(cph(survmod ~ Vac)))
res <- firstCollettAmelia(mod , anovaImp , 70)
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The following code is just a demonstration to use the function secondCollettAmelia. This step
was not automated therefore, the model need to be updated every time a variable is removed.
An example is displayed below.
modf <- with(impData , cph(survmod ~ Vac + CliForm + Sit +
Alc + Prison + HIV + Diabetes + age , x=T, y=T))
logLfull <- NULL
for (k in 1:70) {
fitFull <- modf[[k]]
logLfull[k] <- -2 * fitFull$loglik [2]
}
mod <- with(impData , cph(survmod ~ Vac + CliForm + Sit +
Alc + Prison + HIV , x=T, y=T))
res <- secondCollettAmelia(mod , modf , 70)
Through the lines below, the object is converted in order to pool the results.
# convert the object to the mids class in order to use
pool to combine the results using Rubin ’s rules.
aMids <- datalist2mids(amelia$imputations)
modf <- with(aMids , cph(survmod ~ Vac + CliForm + Sit +
Alc + Prison + HIV + Diabetes + age , x=T, y=T))
fit <- pool(modf)
PMM imputation
# Use matrix of predictors
predMatrix <- quickpred(data1 , method="spearman")
imp <- mice(data1 , m=70, maxit=10, pred=predMatrix , method=
"pmm", seed =71152 , printFlag=TRUE)
The following code is just a demonstration to use the function firstCollettMI. This step was
not automated therefore, these lines need to be run for each variable. An example is displayed
below.
mod <- with(imp , cph(survmod ~ Vac , x=T, y=T))
anovaImp <- with(imp , anova(cph(survmod ~ Vac)))
vals <- firstCollettMI(mod , anovaImp , 70)
The following code is just a demonstration to use the function secondCollettAmelia. This step
was not automated therefore, the model need to be updated every time a variable is removed.
An example is displayed below.
modf <- with(imp , cph(survmod ~ CliForm + Alc + Sit + age +
HIV + Diabetes , x=T, y=T))
logLfull <- NULL
for (k in 1:70) {
fitFull <- modf$analyses [[k]]
logLfull[k] <- -2 * fitFull$loglik [2]
}
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mod <- with(imp , cph(survmod ~ CliForm + Alc + Sit + age +
HIV + Diabetes + Job , x=T, y=T))
vals <- secondCollettMI(mod , modf , 70)
RF - missForest
set.seed (4352)
imp <- missForest(data1 , maxiter =10, ntree =15, verbose=TRUE
)
completeImp <- imp$ximp
The analysis is performed similarly to complete case analysis since the completeImp is one
imputed dataset.
RF - mice
# Use matrix of predictors
predMatrix <- quickpred(data1 , method="spearman")
imp <- mice(data1 , m=70, maxit =10, pred=predMatrix , method=
"rf", seed =71152 , printFlag=TRUE)
The analysis is performed with the functions firstCollettMI and secondCollettMI.
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